,soc,term,subjid,serious,related,fatal,groups
1,Blood and lymphatic system disorders,Anemia,9,0,0,0,Group A
2,Blood and lymphatic system disorders,Anemia,19,0,0,0,Group A
3,Blood and lymphatic system disorders,Anemia,18,0,0,0,Group A
4,Blood and lymphatic system disorders,Anemia,9,0,0,0,Group A
5,Blood and lymphatic system disorders,Anemia,19,0,0,0,Group A
6,Blood and lymphatic system disorders,Anemia,19,0,0,0,Group A
7,Blood and lymphatic system disorders,Anemia,18,0,0,0,Group A
8,Blood and lymphatic system disorders,Anemia,18,0,0,0,Group A
9,Blood and lymphatic system disorders,Anemia,18,0,0,0,Group A
10,Blood and lymphatic system disorders,Anemia,18,0,0,0,Group A
11,Cardiac disorders,Acute coronary syndrome,11,0,0,0,Group A
12,Cardiac disorders,Acute coronary syndrome,2,0,0,0,Group A
13,Cardiac disorders,Acute coronary syndrome,16,0,0,0,Group A
14,Cardiac disorders,Acute coronary syndrome,14,0,0,0,Group A
15,Cardiac disorders,Acute coronary syndrome,11,0,0,0,Group A
16,Cardiac disorders,Acute coronary syndrome,14,0,0,0,Group A
17,Cardiac disorders,Acute coronary syndrome,11,0,0,0,Group A
18,Cardiac disorders,Acute coronary syndrome,11,0,0,0,Group A
19,Cardiac disorders,Acute coronary syndrome,2,0,0,0,Group A
20,Cardiac disorders,Acute coronary syndrome,16,0,0,0,Group A
21,Cardiac disorders,Acute coronary syndrome,11,0,0,0,Group A
22,Cardiac disorders,Acute coronary syndrome,16,0,0,0,Group A
23,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",15,0,0,0,Group A
24,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",17,0,0,0,Group A
25,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",15,0,0,0,Group A
26,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",15,0,0,0,Group A
27,Ear and labyrinth disorders,Ear pain,4,0,0,0,Group A
28,Ear and labyrinth disorders,Ear pain,9,0,0,0,Group A
29,Ear and labyrinth disorders,Ear pain,19,0,0,0,Group A
30,Ear and labyrinth disorders,Ear pain,18,0,0,0,Group A
31,Ear and labyrinth disorders,Ear pain,11,0,0,0,Group A
32,Ear and labyrinth disorders,Ear pain,2,0,0,0,Group A
33,Ear and labyrinth disorders,Ear pain,16,0,0,0,Group A
34,Ear and labyrinth disorders,Ear pain,14,0,0,0,Group A
35,Ear and labyrinth disorders,Ear pain,11,0,0,0,Group A
36,Ear and labyrinth disorders,Ear pain,2,0,0,0,Group A
37,Ear and labyrinth disorders,Ear pain,2,0,0,0,Group A
38,Ear and labyrinth disorders,Ear pain,18,0,0,0,Group A
39,Ear and labyrinth disorders,Ear pain,2,0,0,0,Group A
40,Ear and labyrinth disorders,Ear pain,14,0,0,0,Group A
41,Ear and labyrinth disorders,Ear pain,19,0,0,0,Group A
42,Ear and labyrinth disorders,Ear pain,9,0,0,0,Group A
43,Ear and labyrinth disorders,Ear pain,16,0,0,0,Group A
44,Ear and labyrinth disorders,Ear pain,9,0,0,0,Group A
45,Endocrine disorders,Adrenal insufficiency,15,0,0,0,Group A
46,Endocrine disorders,Adrenal insufficiency,17,0,0,0,Group A
47,Endocrine disorders,Adrenal insufficiency,4,0,0,0,Group A
48,Endocrine disorders,Adrenal insufficiency,9,0,0,0,Group A
49,Endocrine disorders,Adrenal insufficiency,19,0,0,0,Group A
50,Endocrine disorders,Adrenal insufficiency,18,0,0,0,Group A
51,Endocrine disorders,Adrenal insufficiency,11,0,0,0,Group A
52,Endocrine disorders,Adrenal insufficiency,2,0,0,0,Group A
53,Endocrine disorders,Adrenal insufficiency,16,0,0,0,Group A
54,Endocrine disorders,Adrenal insufficiency,14,0,0,0,Group A
55,Endocrine disorders,Adrenal insufficiency,11,0,0,0,Group A
56,Endocrine disorders,Adrenal insufficiency,2,0,0,0,Group A
57,Endocrine disorders,Adrenal insufficiency,19,0,0,0,Group A
58,Endocrine disorders,Adrenal insufficiency,19,0,0,0,Group A
59,Endocrine disorders,Adrenal insufficiency,17,0,0,0,Group A
60,Endocrine disorders,Adrenal insufficiency,15,0,0,0,Group A
61,Endocrine disorders,Adrenal insufficiency,2,0,0,0,Group A
62,Endocrine disorders,Adrenal insufficiency,18,0,0,0,Group A
63,Eye disorders,Blurred vision,15,0,0,0,Group A
64,Eye disorders,Blurred vision,17,0,0,0,Group A
65,Eye disorders,Blurred vision,17,0,0,0,Group A
66,Eye disorders,Blurred vision,17,0,0,0,Group A
67,Eye disorders,Blurred vision,17,0,0,0,Group A
68,Eye disorders,Blurred vision,15,0,0,0,Group A
69,Eye disorders,Blurred vision,17,0,0,0,Group A
70,Gastrointestinal disorders,Abdominal distension,4,0,0,0,Group A
71,Gastrointestinal disorders,Abdominal distension,9,0,0,0,Group A
72,Gastrointestinal disorders,Abdominal distension,19,0,0,0,Group A
73,Gastrointestinal disorders,Abdominal distension,18,0,0,0,Group A
74,Gastrointestinal disorders,Abdominal distension,11,0,0,0,Group A
75,Gastrointestinal disorders,Abdominal distension,2,0,0,0,Group A
76,Gastrointestinal disorders,Abdominal distension,16,0,0,0,Group A
77,Gastrointestinal disorders,Abdominal distension,4,0,0,0,Group A
78,Gastrointestinal disorders,Abdominal distension,11,0,0,0,Group A
79,Gastrointestinal disorders,Abdominal distension,9,0,0,0,Group A
80,Gastrointestinal disorders,Abdominal distension,2,0,0,0,Group A
81,General disorders and administration site conditions,Chills,14,0,0,0,Group A
82,General disorders and administration site conditions,Chills,15,0,0,0,Group A
83,General disorders and administration site conditions,Chills,17,0,0,0,Group A
84,General disorders and administration site conditions,Chills,14,0,0,0,Group A
85,General disorders and administration site conditions,Chills,14,0,0,0,Group A
86,General disorders and administration site conditions,Chills,17,0,0,0,Group A
87,Hepatobiliary disorders,Bile duct stenosis,4,0,0,0,Group A
88,Hepatobiliary disorders,Bile duct stenosis,9,0,0,0,Group A
89,Hepatobiliary disorders,Bile duct stenosis,19,0,0,0,Group A
90,Hepatobiliary disorders,Bile duct stenosis,18,0,0,0,Group A
91,Hepatobiliary disorders,Bile duct stenosis,19,0,0,0,Group A
92,Hepatobiliary disorders,Bile duct stenosis,9,0,0,0,Group A
93,Hepatobiliary disorders,Bile duct stenosis,9,0,0,0,Group A
94,Immune system disorders,Allergic reaction,11,0,0,0,Group A
95,Immune system disorders,Allergic reaction,2,0,0,0,Group A
96,Immune system disorders,Allergic reaction,16,0,0,0,Group A
97,Immune system disorders,Allergic reaction,14,0,0,0,Group A
98,Immune system disorders,Allergic reaction,16,0,0,0,Group A
99,Infections and infestations,Abdominal infection,15,0,0,0,Group A
100,Infections and infestations,Abdominal infection,17,0,0,0,Group A
101,Infections and infestations,Abdominal infection,4,0,0,0,Group A
102,Infections and infestations,Abdominal infection,9,0,0,0,Group A
103,Infections and infestations,Abdominal infection,4,0,0,0,Group A
104,Infections and infestations,Abdominal infection,17,0,0,0,Group A
105,Infections and infestations,Abdominal infection,15,0,0,0,Group A
106,Infections and infestations,Abdominal infection,17,0,0,0,Group A
107,Infections and infestations,Abdominal infection,15,0,0,0,Group A
108,"Injury, poisoning and procedural complications",Ankle fracture,19,0,0,0,Group A
109,"Injury, poisoning and procedural complications",Ankle fracture,18,0,0,0,Group A
110,"Injury, poisoning and procedural complications",Ankle fracture,11,0,0,0,Group A
111,"Injury, poisoning and procedural complications",Ankle fracture,2,0,0,0,Group A
112,"Injury, poisoning and procedural complications",Ankle fracture,16,0,0,0,Group A
113,"Injury, poisoning and procedural complications",Ankle fracture,19,0,0,0,Group A
114,"Injury, poisoning and procedural complications",Ankle fracture,2,0,0,0,Group A
115,"Injury, poisoning and procedural complications",Ankle fracture,18,0,0,0,Group A
116,"Injury, poisoning and procedural complications",Ankle fracture,16,0,0,0,Group A
117,Investigations,Activated partial thromboplastin time prolonged,14,0,0,0,Group A
118,Investigations,Activated partial thromboplastin time prolonged,15,0,0,0,Group A
119,Investigations,Activated partial thromboplastin time prolonged,17,0,0,0,Group A
120,Investigations,Activated partial thromboplastin time prolonged,4,0,0,0,Group A
121,Investigations,Activated partial thromboplastin time prolonged,9,0,0,0,Group A
122,Investigations,Activated partial thromboplastin time prolonged,19,0,0,0,Group A
123,Investigations,Activated partial thromboplastin time prolonged,15,0,0,0,Group A
124,Investigations,Activated partial thromboplastin time prolonged,9,0,0,0,Group A
125,Metabolism and nutrition disorders,Acidosis,18,0,0,0,Group A
126,Metabolism and nutrition disorders,Acidosis,11,0,0,0,Group A
127,Metabolism and nutrition disorders,Acidosis,2,0,0,0,Group A
128,Metabolism and nutrition disorders,Acidosis,16,0,0,0,Group A
129,Metabolism and nutrition disorders,Acidosis,14,0,0,0,Group A
130,Metabolism and nutrition disorders,Acidosis,15,0,0,0,Group A
131,Metabolism and nutrition disorders,Acidosis,18,0,0,0,Group A
132,Metabolism and nutrition disorders,Acidosis,14,0,0,0,Group A
133,Metabolism and nutrition disorders,Acidosis,18,0,0,0,Group A
134,Metabolism and nutrition disorders,Acidosis,16,0,0,0,Group A
135,Metabolism and nutrition disorders,Acidosis,18,0,0,0,Group A
136,Metabolism and nutrition disorders,Acidosis,18,0,0,0,Group A
137,Metabolism and nutrition disorders,Acidosis,2,0,0,0,Group A
138,Metabolism and nutrition disorders,Acidosis,18,0,0,0,Group A
139,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,17,0,0,0,Group A
140,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,4,0,0,0,Group A
141,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,9,0,0,0,Group A
142,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,19,0,0,0,Group A
143,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,4,0,0,0,Group A
144,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,19,0,0,0,Group A
145,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,4,0,0,0,Group A
146,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,9,0,0,0,Group A
147,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,9,0,0,0,Group A
148,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,4,0,0,0,Group A
149,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,18,0,0,0,Group A
150,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,11,0,0,0,Group A
151,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,2,0,0,0,Group A
152,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,16,0,0,0,Group A
153,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,18,0,0,0,Group A
154,Nervous system disorders,Abducens nerve disorder,14,0,0,0,Group A
155,Nervous system disorders,Abducens nerve disorder,15,0,0,0,Group A
156,Nervous system disorders,Abducens nerve disorder,17,0,0,0,Group A
157,Nervous system disorders,Abducens nerve disorder,4,0,0,0,Group A
158,Nervous system disorders,Abducens nerve disorder,9,0,0,0,Group A
159,Nervous system disorders,Abducens nerve disorder,19,0,0,0,Group A
160,Nervous system disorders,Abducens nerve disorder,18,0,0,0,Group A
161,Nervous system disorders,Abducens nerve disorder,19,0,0,0,Group A
162,Nervous system disorders,Abducens nerve disorder,14,0,0,0,Group A
163,Nervous system disorders,Abducens nerve disorder,19,0,0,0,Group A
164,Nervous system disorders,Abducens nerve disorder,19,0,0,0,Group A
165,Nervous system disorders,Abducens nerve disorder,19,0,0,0,Group A
166,Nervous system disorders,Abducens nerve disorder,18,0,0,0,Group A
167,Nervous system disorders,Abducens nerve disorder,4,0,0,0,Group A
168,Nervous system disorders,Abducens nerve disorder,9,0,0,0,Group A
169,Nervous system disorders,Abducens nerve disorder,9,0,0,0,Group A
170,Nervous system disorders,Abducens nerve disorder,18,0,0,0,Group A
171,"Pregnancy, puerperium and perinatal conditions",Fetal death,11,0,0,0,Group A
172,"Pregnancy, puerperium and perinatal conditions",Fetal death,2,0,0,0,Group A
173,"Pregnancy, puerperium and perinatal conditions",Fetal death,16,0,0,0,Group A
174,"Pregnancy, puerperium and perinatal conditions",Fetal death,14,0,0,0,Group A
175,"Pregnancy, puerperium and perinatal conditions",Fetal death,2,0,0,0,Group A
176,"Pregnancy, puerperium and perinatal conditions",Fetal death,2,0,0,0,Group A
177,"Pregnancy, puerperium and perinatal conditions",Fetal death,2,0,0,0,Group A
178,Psychiatric disorders,Agitation,15,0,0,0,Group A
179,Psychiatric disorders,Agitation,17,0,0,0,Group A
180,Psychiatric disorders,Agitation,4,0,0,0,Group A
181,Psychiatric disorders,Agitation,9,0,0,0,Group A
182,Psychiatric disorders,Agitation,19,0,0,0,Group A
183,Renal and urinary disorders,Acute kidney injury,18,0,0,0,Group A
184,Renal and urinary disorders,Acute kidney injury,11,0,0,0,Group A
185,Renal and urinary disorders,Acute kidney injury,11,0,0,0,Group A
186,Renal and urinary disorders,Acute kidney injury,11,0,0,0,Group A
187,Renal and urinary disorders,Acute kidney injury,18,0,0,0,Group A
188,Renal and urinary disorders,Acute kidney injury,18,0,0,0,Group A
189,Renal and urinary disorders,Acute kidney injury,11,0,0,0,Group A
190,Reproductive system and breast disorders,Azoospermia,2,0,0,0,Group A
191,Reproductive system and breast disorders,Azoospermia,16,0,0,0,Group A
192,Reproductive system and breast disorders,Azoospermia,14,0,0,0,Group A
193,Reproductive system and breast disorders,Azoospermia,15,0,0,0,Group A
194,Reproductive system and breast disorders,Azoospermia,17,0,0,0,Group A
195,Reproductive system and breast disorders,Azoospermia,4,0,0,0,Group A
196,Reproductive system and breast disorders,Azoospermia,9,0,0,0,Group A
197,Reproductive system and breast disorders,Azoospermia,19,0,0,0,Group A
198,Reproductive system and breast disorders,Azoospermia,16,0,0,0,Group A
199,Reproductive system and breast disorders,Azoospermia,19,0,0,0,Group A
200,Reproductive system and breast disorders,Azoospermia,9,0,0,0,Group A
201,Reproductive system and breast disorders,Azoospermia,19,0,0,0,Group A
202,Reproductive system and breast disorders,Azoospermia,16,0,0,0,Group A
203,Reproductive system and breast disorders,Azoospermia,16,0,0,0,Group A
204,Reproductive system and breast disorders,Azoospermia,9,0,0,0,Group A
205,Reproductive system and breast disorders,Azoospermia,17,0,0,0,Group A
206,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,18,0,0,0,Group A
207,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,11,0,0,0,Group A
208,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,2,0,0,0,Group A
209,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,16,0,0,0,Group A
210,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,11,0,0,0,Group A
211,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,11,0,0,0,Group A
212,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,11,0,0,0,Group A
213,Skin and subcutaneous tissue disorders,Alopecia,14,0,0,0,Group A
214,Skin and subcutaneous tissue disorders,Alopecia,15,0,0,0,Group A
215,Skin and subcutaneous tissue disorders,Alopecia,17,0,0,0,Group A
216,Skin and subcutaneous tissue disorders,Alopecia,4,0,0,0,Group A
217,Skin and subcutaneous tissue disorders,Alopecia,4,0,0,0,Group A
218,Social circumstances,Menopause,9,0,0,0,Group A
219,Social circumstances,Menopause,19,0,0,0,Group A
220,Social circumstances,Menopause,18,0,0,0,Group A
221,Social circumstances,Menopause,11,0,0,0,Group A
222,Social circumstances,Menopause,2,0,0,0,Group A
223,Social circumstances,Menopause,16,0,0,0,Group A
224,Social circumstances,Menopause,14,0,0,0,Group A
225,Social circumstances,Menopause,15,0,0,0,Group A
226,Social circumstances,Menopause,9,0,0,0,Group A
227,Social circumstances,Menopause,11,0,0,0,Group A
228,Social circumstances,Menopause,15,0,0,0,Group A
229,Social circumstances,Menopause,2,0,0,0,Group A
230,Social circumstances,Menopause,9,0,0,0,Group A
231,Social circumstances,Menopause,14,0,0,0,Group A
232,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",17,0,0,0,Group A
233,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",4,0,0,0,Group A
234,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",9,0,0,0,Group A
235,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",19,0,0,0,Group A
236,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",18,0,0,0,Group A
237,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",11,0,0,0,Group A
238,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",17,0,0,0,Group A
239,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",4,0,0,0,Group A
240,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",18,0,0,0,Group A
241,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",19,0,0,0,Group A
242,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",11,0,0,0,Group A
243,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",9,0,0,0,Group A
244,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",18,0,0,0,Group A
245,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",17,0,0,0,Group A
246,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",4,0,0,0,Group A
247,Vascular disorders,Capillary leak syndrome,2,0,0,0,Group A
248,Vascular disorders,Capillary leak syndrome,16,0,0,0,Group A
249,Vascular disorders,Capillary leak syndrome,2,0,0,0,Group A
250,Vascular disorders,Capillary leak syndrome,16,0,0,0,Group A
251,Vascular disorders,Capillary leak syndrome,2,0,0,0,Group A
252,Vascular disorders,Capillary leak syndrome,16,0,0,0,Group A
253,Vascular disorders,Capillary leak syndrome,2,0,0,0,Group A
254,Vascular disorders,Capillary leak syndrome,16,0,0,0,Group A
255,Blood and lymphatic system disorders,Anemia,13,1,1,0,Group A
256,Blood and lymphatic system disorders,Anemia,3,1,0,0,Group A
257,Blood and lymphatic system disorders,Anemia,8,1,0,0,Group A
258,Blood and lymphatic system disorders,Anemia,18,1,1,0,Group A
259,Blood and lymphatic system disorders,Anemia,6,1,0,0,Group A
260,Blood and lymphatic system disorders,Anemia,15,1,0,0,Group A
261,Cardiac disorders,Acute coronary syndrome,1,1,0,0,Group A
262,Cardiac disorders,Acute coronary syndrome,4,1,0,0,Group A
263,Cardiac disorders,Acute coronary syndrome,14,1,1,0,Group A
264,Cardiac disorders,Acute coronary syndrome,4,1,1,0,Group A
265,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",16,1,1,0,Group A
266,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",13,1,1,0,Group A
267,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",3,1,0,0,Group A
268,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",8,1,1,0,Group A
269,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",18,1,1,0,Group A
270,Ear and labyrinth disorders,Ear pain,6,1,0,0,Group A
271,Ear and labyrinth disorders,Ear pain,15,1,0,0,Group A
272,Ear and labyrinth disorders,Ear pain,6,1,1,0,Group A
273,Ear and labyrinth disorders,Ear pain,6,1,1,0,Group A
274,Ear and labyrinth disorders,Ear pain,6,1,1,0,Group A
275,Ear and labyrinth disorders,Ear pain,15,1,0,0,Group A
276,Ear and labyrinth disorders,Ear pain,6,1,0,0,Group A
277,Ear and labyrinth disorders,Ear pain,6,1,1,0,Group A
278,Ear and labyrinth disorders,Ear pain,6,1,0,0,Group A
279,Endocrine disorders,Adrenal insufficiency,1,1,0,0,Group A
280,Endocrine disorders,Adrenal insufficiency,4,1,0,0,Group A
281,Endocrine disorders,Adrenal insufficiency,14,1,1,0,Group A
282,Endocrine disorders,Adrenal insufficiency,16,1,0,0,Group A
283,Endocrine disorders,Adrenal insufficiency,13,1,0,0,Group A
284,Endocrine disorders,Adrenal insufficiency,13,1,1,0,Group A
285,Endocrine disorders,Adrenal insufficiency,4,1,1,0,Group A
286,Endocrine disorders,Adrenal insufficiency,4,1,0,0,Group A
287,Endocrine disorders,Adrenal insufficiency,4,1,1,0,Group A
288,Endocrine disorders,Adrenal insufficiency,16,1,0,0,Group A
289,Endocrine disorders,Adrenal insufficiency,14,1,0,0,Group A
290,Endocrine disorders,Adrenal insufficiency,16,1,0,0,Group A
291,Eye disorders,Blurred vision,3,1,0,0,Group A
292,Eye disorders,Blurred vision,8,1,1,0,Group A
293,Eye disorders,Blurred vision,18,1,0,0,Group A
294,Eye disorders,Blurred vision,6,1,0,0,Group A
295,Eye disorders,Blurred vision,15,1,1,0,Group A
296,Eye disorders,Blurred vision,1,1,0,0,Group A
297,Eye disorders,Blurred vision,8,1,0,0,Group A
298,Eye disorders,Blurred vision,1,1,0,0,Group A
299,Eye disorders,Blurred vision,1,1,0,0,Group A
300,Eye disorders,Blurred vision,6,1,0,0,Group A
301,Eye disorders,Blurred vision,3,1,1,0,Group A
302,Eye disorders,Blurred vision,15,1,0,0,Group A
303,Eye disorders,Blurred vision,8,1,0,0,Group A
304,Eye disorders,Blurred vision,1,1,0,0,Group A
305,Eye disorders,Blurred vision,8,1,1,0,Group A
306,Eye disorders,Blurred vision,6,1,0,0,Group A
307,Gastrointestinal disorders,Abdominal distension,14,1,0,1,Group A
308,Gastrointestinal disorders,Abdominal distension,4,1,1,0,Group A
309,Gastrointestinal disorders,Abdominal distension,16,1,0,0,Group A
310,Gastrointestinal disorders,Abdominal distension,13,1,0,0,Group A
311,Gastrointestinal disorders,Abdominal distension,3,1,1,0,Group A
312,Gastrointestinal disorders,Abdominal distension,8,1,0,0,Group A
313,Gastrointestinal disorders,Abdominal distension,18,1,0,0,Group A
314,Gastrointestinal disorders,Abdominal distension,13,1,0,0,Group A
315,General disorders and administration site conditions,Chills,6,1,0,0,Group A
316,General disorders and administration site conditions,Chills,15,1,0,0,Group A
317,General disorders and administration site conditions,Chills,1,1,1,0,Group A
318,General disorders and administration site conditions,Chills,4,1,0,0,Group A
319,General disorders and administration site conditions,Chills,14,1,1,0,Group A
320,General disorders and administration site conditions,Chills,16,1,1,0,Group A
321,General disorders and administration site conditions,Chills,13,1,1,0,Group A
322,General disorders and administration site conditions,Chills,3,1,0,0,Group A
323,General disorders and administration site conditions,Chills,8,1,0,0,Group A
324,General disorders and administration site conditions,Chills,18,1,0,0,Group A
325,General disorders and administration site conditions,Chills,16,1,1,0,Group A
326,General disorders and administration site conditions,Chills,1,1,1,0,Group A
327,General disorders and administration site conditions,Chills,8,1,1,0,Group A
328,General disorders and administration site conditions,Chills,16,1,1,0,Group A
329,General disorders and administration site conditions,Chills,1,1,1,0,Group A
330,General disorders and administration site conditions,Chills,8,1,1,0,Group A
331,General disorders and administration site conditions,Chills,18,1,1,0,Group A
332,General disorders and administration site conditions,Chills,4,1,0,0,Group A
333,General disorders and administration site conditions,Chills,15,1,0,0,Group A
334,General disorders and administration site conditions,Chills,15,1,1,0,Group A
335,Hepatobiliary disorders,Bile duct stenosis,6,1,0,0,Group A
336,Hepatobiliary disorders,Bile duct stenosis,15,1,0,0,Group A
337,Hepatobiliary disorders,Bile duct stenosis,1,1,1,0,Group A
338,Hepatobiliary disorders,Bile duct stenosis,4,1,0,0,Group A
339,Hepatobiliary disorders,Bile duct stenosis,14,1,0,0,Group A
340,Immune system disorders,Allergic reaction,16,1,1,0,Group A
341,Immune system disorders,Allergic reaction,13,1,0,0,Group A
342,Immune system disorders,Allergic reaction,3,1,1,0,Group A
343,Immune system disorders,Allergic reaction,8,1,0,0,Group A
344,Immune system disorders,Allergic reaction,18,1,0,0,Group A
345,Immune system disorders,Allergic reaction,6,1,0,0,Group A
346,Immune system disorders,Allergic reaction,15,1,0,0,Group A
347,Immune system disorders,Allergic reaction,8,1,0,0,Group A
348,Immune system disorders,Allergic reaction,8,1,1,0,Group A
349,Immune system disorders,Allergic reaction,16,1,0,0,Group A
350,Infections and infestations,Abdominal infection,1,1,1,0,Group A
351,Infections and infestations,Abdominal infection,4,1,0,0,Group A
352,Infections and infestations,Abdominal infection,14,1,0,0,Group A
353,Infections and infestations,Abdominal infection,14,1,0,0,Group A
354,Infections and infestations,Abdominal infection,1,1,1,0,Group A
355,Infections and infestations,Abdominal infection,4,1,1,0,Group A
356,Infections and infestations,Abdominal infection,4,1,0,0,Group A
357,"Injury, poisoning and procedural complications",Ankle fracture,16,1,1,0,Group A
358,"Injury, poisoning and procedural complications",Ankle fracture,13,1,1,0,Group A
359,"Injury, poisoning and procedural complications",Ankle fracture,3,1,1,0,Group A
360,"Injury, poisoning and procedural complications",Ankle fracture,8,1,1,0,Group A
361,"Injury, poisoning and procedural complications",Ankle fracture,18,1,0,0,Group A
362,"Injury, poisoning and procedural complications",Ankle fracture,18,1,1,0,Group A
363,Investigations,Activated partial thromboplastin time prolonged,8,1,1,1,Group A
364,Investigations,Activated partial thromboplastin time prolonged,15,1,0,0,Group A
365,Investigations,Activated partial thromboplastin time prolonged,1,1,1,0,Group A
366,Investigations,Activated partial thromboplastin time prolonged,4,1,0,0,Group A
367,Investigations,Activated partial thromboplastin time prolonged,4,1,1,0,Group A
368,Investigations,Activated partial thromboplastin time prolonged,1,1,1,0,Group A
369,Investigations,Activated partial thromboplastin time prolonged,15,1,0,0,Group A
370,Investigations,Activated partial thromboplastin time prolonged,1,1,0,0,Group A
371,Metabolism and nutrition disorders,Acidosis,4,1,0,0,Group A
372,Metabolism and nutrition disorders,Acidosis,14,1,0,0,Group A
373,Metabolism and nutrition disorders,Acidosis,16,1,1,0,Group A
374,Metabolism and nutrition disorders,Acidosis,13,1,0,0,Group A
375,Metabolism and nutrition disorders,Acidosis,3,1,1,0,Group A
376,Metabolism and nutrition disorders,Acidosis,8,1,0,0,Group A
377,Metabolism and nutrition disorders,Acidosis,18,1,0,0,Group A
378,Metabolism and nutrition disorders,Acidosis,6,1,0,0,Group A
379,Metabolism and nutrition disorders,Acidosis,4,1,0,0,Group A
380,Metabolism and nutrition disorders,Acidosis,16,1,0,0,Group A
381,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,4,1,0,1,Group A
382,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,15,1,1,0,Group A
383,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,1,1,0,0,Group A
384,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,14,1,1,0,Group A
385,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,16,1,0,0,Group A
386,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,14,1,1,0,Group A
387,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,15,1,1,0,Group A
388,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,16,1,0,0,Group A
389,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,4,1,0,0,Group A
390,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,16,1,0,0,Group A
391,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,15,1,0,0,Group A
392,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,4,1,0,0,Group A
393,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,16,1,0,0,Group A
394,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,13,1,1,0,Group A
395,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,3,1,0,0,Group A
396,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,8,1,1,0,Group A
397,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,18,1,1,0,Group A
398,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,8,1,0,0,Group A
399,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,3,1,1,0,Group A
400,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,13,1,1,0,Group A
401,Nervous system disorders,Abducens nerve disorder,6,1,0,0,Group A
402,Nervous system disorders,Abducens nerve disorder,15,1,1,0,Group A
403,Nervous system disorders,Abducens nerve disorder,1,1,1,0,Group A
404,Nervous system disorders,Abducens nerve disorder,4,1,1,0,Group A
405,Nervous system disorders,Abducens nerve disorder,14,1,0,0,Group A
406,Nervous system disorders,Abducens nerve disorder,4,1,1,0,Group A
407,Nervous system disorders,Abducens nerve disorder,6,1,1,0,Group A
408,Nervous system disorders,Abducens nerve disorder,15,1,0,0,Group A
409,"Pregnancy, puerperium and perinatal conditions",Fetal death,16,1,0,0,Group A
410,"Pregnancy, puerperium and perinatal conditions",Fetal death,13,1,1,0,Group A
411,"Pregnancy, puerperium and perinatal conditions",Fetal death,3,1,1,0,Group A
412,"Pregnancy, puerperium and perinatal conditions",Fetal death,3,1,0,0,Group A
413,"Pregnancy, puerperium and perinatal conditions",Fetal death,13,1,1,0,Group A
414,"Pregnancy, puerperium and perinatal conditions",Fetal death,13,1,1,0,Group A
415,"Pregnancy, puerperium and perinatal conditions",Fetal death,16,1,0,0,Group A
416,Psychiatric disorders,Agitation,8,1,0,0,Group A
417,Psychiatric disorders,Agitation,18,1,1,0,Group A
418,Psychiatric disorders,Agitation,6,1,0,0,Group A
419,Psychiatric disorders,Agitation,15,1,1,0,Group A
420,Psychiatric disorders,Agitation,1,1,1,0,Group A
421,Psychiatric disorders,Agitation,4,1,0,0,Group A
422,Psychiatric disorders,Agitation,1,1,1,0,Group A
423,Psychiatric disorders,Agitation,15,1,0,0,Group A
424,Renal and urinary disorders,Acute kidney injury,14,1,0,0,Group A
425,Renal and urinary disorders,Acute kidney injury,16,1,1,0,Group A
426,Renal and urinary disorders,Acute kidney injury,13,1,1,0,Group A
427,Renal and urinary disorders,Acute kidney injury,3,1,1,0,Group A
428,Renal and urinary disorders,Acute kidney injury,16,1,0,0,Group A
429,Reproductive system and breast disorders,Azoospermia,8,1,1,0,Group A
430,Reproductive system and breast disorders,Azoospermia,18,1,0,0,Group A
431,Reproductive system and breast disorders,Azoospermia,6,1,1,0,Group A
432,Reproductive system and breast disorders,Azoospermia,15,1,1,0,Group A
433,Reproductive system and breast disorders,Azoospermia,1,1,1,0,Group A
434,Reproductive system and breast disorders,Azoospermia,1,1,0,0,Group A
435,Reproductive system and breast disorders,Azoospermia,1,1,0,0,Group A
436,Reproductive system and breast disorders,Azoospermia,6,1,1,0,Group A
437,Reproductive system and breast disorders,Azoospermia,18,1,0,0,Group A
438,Reproductive system and breast disorders,Azoospermia,8,1,0,0,Group A
439,Reproductive system and breast disorders,Azoospermia,8,1,1,0,Group A
440,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,4,1,0,0,Group A
441,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,14,1,0,0,Group A
442,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,16,1,1,0,Group A
443,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,13,1,1,0,Group A
444,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,3,1,0,0,Group A
445,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,8,1,1,0,Group A
446,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,18,1,0,0,Group A
447,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,18,1,1,0,Group A
448,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,4,1,1,0,Group A
449,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,16,1,1,0,Group A
450,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,14,1,1,0,Group A
451,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,8,1,1,0,Group A
452,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,14,1,1,0,Group A
453,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,18,1,0,0,Group A
454,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,14,1,1,0,Group A
455,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,8,1,0,0,Group A
456,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,18,1,0,0,Group A
457,Skin and subcutaneous tissue disorders,Alopecia,6,1,0,0,Group A
458,Skin and subcutaneous tissue disorders,Alopecia,15,1,1,0,Group A
459,Skin and subcutaneous tissue disorders,Alopecia,1,1,0,0,Group A
460,Skin and subcutaneous tissue disorders,Alopecia,15,1,0,0,Group A
461,Skin and subcutaneous tissue disorders,Alopecia,1,1,0,0,Group A
462,Skin and subcutaneous tissue disorders,Alopecia,6,1,1,0,Group A
463,Social circumstances,Menopause,4,1,1,0,Group A
464,Social circumstances,Menopause,14,1,1,0,Group A
465,Social circumstances,Menopause,16,1,0,0,Group A
466,Social circumstances,Menopause,13,1,1,0,Group A
467,Social circumstances,Menopause,3,1,0,0,Group A
468,Social circumstances,Menopause,8,1,0,0,Group A
469,Social circumstances,Menopause,18,1,0,0,Group A
470,Social circumstances,Menopause,6,1,0,0,Group A
471,Social circumstances,Menopause,4,1,1,0,Group A
472,Social circumstances,Menopause,14,1,0,0,Group A
473,Social circumstances,Menopause,3,1,0,0,Group A
474,Social circumstances,Menopause,18,1,1,0,Group A
475,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",15,1,1,0,Group A
476,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",1,1,1,0,Group A
477,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",4,1,0,0,Group A
478,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",14,1,0,0,Group A
479,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",16,1,1,0,Group A
480,Vascular disorders,Capillary leak syndrome,13,1,1,0,Group A
481,Vascular disorders,Capillary leak syndrome,3,1,1,0,Group A
482,Vascular disorders,Capillary leak syndrome,8,1,0,0,Group A
483,Vascular disorders,Capillary leak syndrome,18,1,1,0,Group A
484,Vascular disorders,Capillary leak syndrome,13,1,1,0,Group A
485,Vascular disorders,Capillary leak syndrome,8,1,0,0,Group A
486,Vascular disorders,Capillary leak syndrome,8,1,0,0,Group A
487,Vascular disorders,Capillary leak syndrome,13,1,1,0,Group A
488,Vascular disorders,Capillary leak syndrome,13,1,1,0,Group A
489,Vascular disorders,Capillary leak syndrome,18,1,1,0,Group A
490,Vascular disorders,Capillary leak syndrome,18,1,1,0,Group A
491,Vascular disorders,Capillary leak syndrome,13,1,0,0,Group A
492,Blood and lymphatic system disorders,Anemia,29,0,0,0,Group B
493,Blood and lymphatic system disorders,Anemia,39,0,0,0,Group B
494,Blood and lymphatic system disorders,Anemia,26,0,0,0,Group B
495,Blood and lymphatic system disorders,Anemia,27,0,0,0,Group B
496,Blood and lymphatic system disorders,Anemia,38,0,0,0,Group B
497,Blood and lymphatic system disorders,Anemia,35,0,0,0,Group B
498,Blood and lymphatic system disorders,Anemia,38,0,0,0,Group B
499,Blood and lymphatic system disorders,Anemia,38,0,0,0,Group B
500,Blood and lymphatic system disorders,Anemia,27,0,0,0,Group B
501,Blood and lymphatic system disorders,Anemia,26,0,0,0,Group B
502,Blood and lymphatic system disorders,Anemia,26,0,0,0,Group B
503,Blood and lymphatic system disorders,Anemia,35,0,0,0,Group B
504,Blood and lymphatic system disorders,Anemia,39,0,0,0,Group B
505,Blood and lymphatic system disorders,Anemia,35,0,0,0,Group B
506,Cardiac disorders,Acute coronary syndrome,34,0,0,0,Group B
507,Cardiac disorders,Acute coronary syndrome,21,0,0,0,Group B
508,Cardiac disorders,Acute coronary syndrome,32,0,0,0,Group B
509,Cardiac disorders,Acute coronary syndrome,42,0,0,0,Group B
510,Cardiac disorders,Acute coronary syndrome,36,0,0,0,Group B
511,Cardiac disorders,Acute coronary syndrome,37,0,0,0,Group B
512,Cardiac disorders,Acute coronary syndrome,24,0,0,0,Group B
513,Cardiac disorders,Acute coronary syndrome,31,0,0,0,Group B
514,Cardiac disorders,Acute coronary syndrome,29,0,0,0,Group B
515,Cardiac disorders,Acute coronary syndrome,39,0,0,0,Group B
516,Cardiac disorders,Acute coronary syndrome,26,0,0,0,Group B
517,Cardiac disorders,Acute coronary syndrome,26,0,0,0,Group B
518,Cardiac disorders,Acute coronary syndrome,29,0,0,0,Group B
519,Cardiac disorders,Acute coronary syndrome,31,0,0,0,Group B
520,Cardiac disorders,Acute coronary syndrome,34,0,0,0,Group B
521,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",27,0,0,0,Group B
522,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",38,0,0,0,Group B
523,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",35,0,0,0,Group B
524,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",34,0,0,0,Group B
525,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",21,0,0,0,Group B
526,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",32,0,0,0,Group B
527,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",32,0,0,0,Group B
528,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",21,0,0,0,Group B
529,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",21,0,0,0,Group B
530,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",35,0,0,0,Group B
531,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",21,0,0,0,Group B
532,Ear and labyrinth disorders,Ear pain,42,0,0,0,Group B
533,Ear and labyrinth disorders,Ear pain,36,0,0,0,Group B
534,Ear and labyrinth disorders,Ear pain,37,0,0,0,Group B
535,Ear and labyrinth disorders,Ear pain,24,0,0,0,Group B
536,Ear and labyrinth disorders,Ear pain,31,0,0,0,Group B
537,Ear and labyrinth disorders,Ear pain,29,0,0,0,Group B
538,Ear and labyrinth disorders,Ear pain,39,0,0,0,Group B
539,Ear and labyrinth disorders,Ear pain,37,0,0,0,Group B
540,Ear and labyrinth disorders,Ear pain,37,0,0,0,Group B
541,Ear and labyrinth disorders,Ear pain,39,0,0,0,Group B
542,Ear and labyrinth disorders,Ear pain,31,0,0,0,Group B
543,Ear and labyrinth disorders,Ear pain,39,0,0,0,Group B
544,Ear and labyrinth disorders,Ear pain,37,0,0,0,Group B
545,Ear and labyrinth disorders,Ear pain,37,0,0,0,Group B
546,Ear and labyrinth disorders,Ear pain,29,0,0,0,Group B
547,Ear and labyrinth disorders,Ear pain,39,0,0,0,Group B
548,Endocrine disorders,Adrenal insufficiency,26,0,0,0,Group B
549,Endocrine disorders,Adrenal insufficiency,27,0,0,0,Group B
550,Endocrine disorders,Adrenal insufficiency,38,0,0,0,Group B
551,Endocrine disorders,Adrenal insufficiency,35,0,0,0,Group B
552,Endocrine disorders,Adrenal insufficiency,34,0,0,0,Group B
553,Endocrine disorders,Adrenal insufficiency,26,0,0,0,Group B
554,Endocrine disorders,Adrenal insufficiency,35,0,0,0,Group B
555,Endocrine disorders,Adrenal insufficiency,34,0,0,0,Group B
556,Endocrine disorders,Adrenal insufficiency,38,0,0,0,Group B
557,Endocrine disorders,Adrenal insufficiency,38,0,0,0,Group B
558,Endocrine disorders,Adrenal insufficiency,38,0,0,0,Group B
559,Eye disorders,Blurred vision,21,0,0,0,Group B
560,Eye disorders,Blurred vision,32,0,0,0,Group B
561,Eye disorders,Blurred vision,42,0,0,0,Group B
562,Eye disorders,Blurred vision,36,0,0,0,Group B
563,Eye disorders,Blurred vision,37,0,0,0,Group B
564,Eye disorders,Blurred vision,24,0,0,0,Group B
565,Eye disorders,Blurred vision,32,0,0,0,Group B
566,Eye disorders,Blurred vision,36,0,0,0,Group B
567,Eye disorders,Blurred vision,24,0,0,0,Group B
568,Gastrointestinal disorders,Abdominal distension,31,0,0,0,Group B
569,Gastrointestinal disorders,Abdominal distension,29,0,0,0,Group B
570,Gastrointestinal disorders,Abdominal distension,39,0,0,0,Group B
571,Gastrointestinal disorders,Abdominal distension,26,0,0,0,Group B
572,Gastrointestinal disorders,Abdominal distension,27,0,0,0,Group B
573,Gastrointestinal disorders,Abdominal distension,38,0,0,0,Group B
574,Gastrointestinal disorders,Abdominal distension,35,0,0,0,Group B
575,Gastrointestinal disorders,Abdominal distension,34,0,0,0,Group B
576,Gastrointestinal disorders,Abdominal distension,29,0,0,0,Group B
577,Gastrointestinal disorders,Abdominal distension,26,0,0,0,Group B
578,Gastrointestinal disorders,Abdominal distension,35,0,0,0,Group B
579,Gastrointestinal disorders,Abdominal distension,39,0,0,0,Group B
580,Gastrointestinal disorders,Abdominal distension,34,0,0,0,Group B
581,Gastrointestinal disorders,Abdominal distension,34,0,0,0,Group B
582,Gastrointestinal disorders,Abdominal distension,26,0,0,0,Group B
583,Gastrointestinal disorders,Abdominal distension,27,0,0,0,Group B
584,General disorders and administration site conditions,Chills,21,0,0,0,Group B
585,General disorders and administration site conditions,Chills,32,0,0,0,Group B
586,General disorders and administration site conditions,Chills,42,0,0,0,Group B
587,General disorders and administration site conditions,Chills,36,0,0,0,Group B
588,General disorders and administration site conditions,Chills,37,0,0,0,Group B
589,General disorders and administration site conditions,Chills,36,0,0,0,Group B
590,General disorders and administration site conditions,Chills,42,0,0,0,Group B
591,General disorders and administration site conditions,Chills,32,0,0,0,Group B
592,Hepatobiliary disorders,Bile duct stenosis,24,0,0,0,Group B
593,Hepatobiliary disorders,Bile duct stenosis,31,0,0,0,Group B
594,Hepatobiliary disorders,Bile duct stenosis,29,0,0,0,Group B
595,Hepatobiliary disorders,Bile duct stenosis,39,0,0,0,Group B
596,Hepatobiliary disorders,Bile duct stenosis,26,0,0,0,Group B
597,Hepatobiliary disorders,Bile duct stenosis,27,0,0,0,Group B
598,Hepatobiliary disorders,Bile duct stenosis,38,0,0,0,Group B
599,Hepatobiliary disorders,Bile duct stenosis,35,0,0,0,Group B
600,Hepatobiliary disorders,Bile duct stenosis,29,0,0,0,Group B
601,Hepatobiliary disorders,Bile duct stenosis,27,0,0,0,Group B
602,Hepatobiliary disorders,Bile duct stenosis,31,0,0,0,Group B
603,Hepatobiliary disorders,Bile duct stenosis,39,0,0,0,Group B
604,Hepatobiliary disorders,Bile duct stenosis,31,0,0,0,Group B
605,Hepatobiliary disorders,Bile duct stenosis,26,0,0,0,Group B
606,Hepatobiliary disorders,Bile duct stenosis,27,0,0,0,Group B
607,Hepatobiliary disorders,Bile duct stenosis,38,0,0,0,Group B
608,Immune system disorders,Allergic reaction,34,0,0,0,Group B
609,Immune system disorders,Allergic reaction,21,0,0,0,Group B
610,Immune system disorders,Allergic reaction,32,0,0,0,Group B
611,Immune system disorders,Allergic reaction,42,0,0,0,Group B
612,Immune system disorders,Allergic reaction,36,0,0,0,Group B
613,Immune system disorders,Allergic reaction,37,0,0,0,Group B
614,Immune system disorders,Allergic reaction,24,0,0,0,Group B
615,Immune system disorders,Allergic reaction,31,0,0,0,Group B
616,Immune system disorders,Allergic reaction,29,0,0,0,Group B
617,Immune system disorders,Allergic reaction,34,0,0,0,Group B
618,Immune system disorders,Allergic reaction,36,0,0,0,Group B
619,Immune system disorders,Allergic reaction,34,0,0,0,Group B
620,Immune system disorders,Allergic reaction,32,0,0,0,Group B
621,Immune system disorders,Allergic reaction,36,0,0,0,Group B
622,Immune system disorders,Allergic reaction,37,0,0,0,Group B
623,Immune system disorders,Allergic reaction,34,0,0,0,Group B
624,Immune system disorders,Allergic reaction,31,0,0,0,Group B
625,Infections and infestations,Abdominal infection,39,0,0,0,Group B
626,Infections and infestations,Abdominal infection,26,0,0,0,Group B
627,Infections and infestations,Abdominal infection,27,0,0,0,Group B
628,Infections and infestations,Abdominal infection,38,0,0,0,Group B
629,Infections and infestations,Abdominal infection,26,0,0,0,Group B
630,Infections and infestations,Abdominal infection,39,0,0,0,Group B
631,Infections and infestations,Abdominal infection,39,0,0,0,Group B
632,Infections and infestations,Abdominal infection,26,0,0,0,Group B
633,Infections and infestations,Abdominal infection,26,0,0,0,Group B
634,Infections and infestations,Abdominal infection,27,0,0,0,Group B
635,Infections and infestations,Abdominal infection,26,0,0,0,Group B
636,Infections and infestations,Abdominal infection,27,0,0,0,Group B
637,Infections and infestations,Abdominal infection,27,0,0,0,Group B
638,Infections and infestations,Abdominal infection,38,0,0,0,Group B
639,"Injury, poisoning and procedural complications",Ankle fracture,35,0,0,0,Group B
640,"Injury, poisoning and procedural complications",Ankle fracture,34,0,0,0,Group B
641,"Injury, poisoning and procedural complications",Ankle fracture,21,0,0,0,Group B
642,"Injury, poisoning and procedural complications",Ankle fracture,32,0,0,0,Group B
643,"Injury, poisoning and procedural complications",Ankle fracture,21,0,0,0,Group B
644,"Injury, poisoning and procedural complications",Ankle fracture,21,0,0,0,Group B
645,"Injury, poisoning and procedural complications",Ankle fracture,32,0,0,0,Group B
646,"Injury, poisoning and procedural complications",Ankle fracture,32,0,0,0,Group B
647,"Injury, poisoning and procedural complications",Ankle fracture,32,0,0,0,Group B
648,"Injury, poisoning and procedural complications",Ankle fracture,34,0,0,0,Group B
649,"Injury, poisoning and procedural complications",Ankle fracture,34,0,0,0,Group B
650,"Injury, poisoning and procedural complications",Ankle fracture,35,0,0,0,Group B
651,"Injury, poisoning and procedural complications",Ankle fracture,35,0,0,0,Group B
652,"Injury, poisoning and procedural complications",Ankle fracture,32,0,0,0,Group B
653,Investigations,Activated partial thromboplastin time prolonged,42,0,0,0,Group B
654,Investigations,Activated partial thromboplastin time prolonged,36,0,0,0,Group B
655,Investigations,Activated partial thromboplastin time prolonged,37,0,0,0,Group B
656,Investigations,Activated partial thromboplastin time prolonged,24,0,0,0,Group B
657,Investigations,Activated partial thromboplastin time prolonged,31,0,0,0,Group B
658,Investigations,Activated partial thromboplastin time prolonged,29,0,0,0,Group B
659,Investigations,Activated partial thromboplastin time prolonged,31,0,0,0,Group B
660,Investigations,Activated partial thromboplastin time prolonged,31,0,0,0,Group B
661,Investigations,Activated partial thromboplastin time prolonged,42,0,0,0,Group B
662,Investigations,Activated partial thromboplastin time prolonged,29,0,0,0,Group B
663,Investigations,Activated partial thromboplastin time prolonged,36,0,0,0,Group B
664,Investigations,Activated partial thromboplastin time prolonged,36,0,0,0,Group B
665,Investigations,Activated partial thromboplastin time prolonged,29,0,0,0,Group B
666,Investigations,Activated partial thromboplastin time prolonged,42,0,0,0,Group B
667,Metabolism and nutrition disorders,Acidosis,39,0,0,0,Group B
668,Metabolism and nutrition disorders,Acidosis,26,0,0,0,Group B
669,Metabolism and nutrition disorders,Acidosis,27,0,0,0,Group B
670,Metabolism and nutrition disorders,Acidosis,38,0,0,0,Group B
671,Metabolism and nutrition disorders,Acidosis,35,0,0,0,Group B
672,Metabolism and nutrition disorders,Acidosis,35,0,0,0,Group B
673,Metabolism and nutrition disorders,Acidosis,26,0,0,0,Group B
674,Metabolism and nutrition disorders,Acidosis,27,0,0,0,Group B
675,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,34,0,0,0,Group B
676,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,21,0,0,0,Group B
677,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,32,0,0,0,Group B
678,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,34,0,0,0,Group B
679,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,34,0,0,0,Group B
680,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,34,0,0,0,Group B
681,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,34,0,0,0,Group B
682,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,21,0,0,0,Group B
683,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,21,0,0,0,Group B
684,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,34,0,0,0,Group B
685,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,34,0,0,0,Group B
686,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,42,0,0,0,Group B
687,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,36,0,0,0,Group B
688,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,37,0,0,0,Group B
689,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,24,0,0,0,Group B
690,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,36,0,0,0,Group B
691,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,36,0,0,0,Group B
692,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,37,0,0,0,Group B
693,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,42,0,0,0,Group B
694,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,24,0,0,0,Group B
695,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,37,0,0,0,Group B
696,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,42,0,0,0,Group B
697,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,24,0,0,0,Group B
698,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,24,0,0,0,Group B
699,Nervous system disorders,Abducens nerve disorder,31,0,0,0,Group B
700,Nervous system disorders,Abducens nerve disorder,29,0,0,0,Group B
701,Nervous system disorders,Abducens nerve disorder,39,0,0,0,Group B
702,Nervous system disorders,Abducens nerve disorder,26,0,0,0,Group B
703,Nervous system disorders,Abducens nerve disorder,27,0,0,0,Group B
704,Nervous system disorders,Abducens nerve disorder,38,0,0,0,Group B
705,Nervous system disorders,Abducens nerve disorder,35,0,0,0,Group B
706,Nervous system disorders,Abducens nerve disorder,34,0,0,0,Group B
707,Nervous system disorders,Abducens nerve disorder,27,0,0,0,Group B
708,Nervous system disorders,Abducens nerve disorder,38,0,0,0,Group B
709,Nervous system disorders,Abducens nerve disorder,39,0,0,0,Group B
710,"Pregnancy, puerperium and perinatal conditions",Fetal death,21,0,0,0,Group B
711,"Pregnancy, puerperium and perinatal conditions",Fetal death,32,0,0,0,Group B
712,"Pregnancy, puerperium and perinatal conditions",Fetal death,42,0,0,0,Group B
713,"Pregnancy, puerperium and perinatal conditions",Fetal death,36,0,0,0,Group B
714,"Pregnancy, puerperium and perinatal conditions",Fetal death,37,0,0,0,Group B
715,"Pregnancy, puerperium and perinatal conditions",Fetal death,24,0,0,0,Group B
716,"Pregnancy, puerperium and perinatal conditions",Fetal death,31,0,0,0,Group B
717,"Pregnancy, puerperium and perinatal conditions",Fetal death,29,0,0,0,Group B
718,"Pregnancy, puerperium and perinatal conditions",Fetal death,39,0,0,0,Group B
719,"Pregnancy, puerperium and perinatal conditions",Fetal death,26,0,0,0,Group B
720,"Pregnancy, puerperium and perinatal conditions",Fetal death,27,0,0,0,Group B
721,"Pregnancy, puerperium and perinatal conditions",Fetal death,38,0,0,0,Group B
722,"Pregnancy, puerperium and perinatal conditions",Fetal death,35,0,0,0,Group B
723,"Pregnancy, puerperium and perinatal conditions",Fetal death,34,0,0,0,Group B
724,"Pregnancy, puerperium and perinatal conditions",Fetal death,26,0,0,0,Group B
725,"Pregnancy, puerperium and perinatal conditions",Fetal death,35,0,0,0,Group B
726,"Pregnancy, puerperium and perinatal conditions",Fetal death,31,0,0,0,Group B
727,"Pregnancy, puerperium and perinatal conditions",Fetal death,26,0,0,0,Group B
728,"Pregnancy, puerperium and perinatal conditions",Fetal death,38,0,0,0,Group B
729,"Pregnancy, puerperium and perinatal conditions",Fetal death,38,0,0,0,Group B
730,"Pregnancy, puerperium and perinatal conditions",Fetal death,42,0,0,0,Group B
731,"Pregnancy, puerperium and perinatal conditions",Fetal death,37,0,0,0,Group B
732,Psychiatric disorders,Agitation,21,0,0,0,Group B
733,Psychiatric disorders,Agitation,32,0,0,0,Group B
734,Psychiatric disorders,Agitation,42,0,0,0,Group B
735,Psychiatric disorders,Agitation,36,0,0,0,Group B
736,Psychiatric disorders,Agitation,21,0,0,0,Group B
737,Psychiatric disorders,Agitation,42,0,0,0,Group B
738,Psychiatric disorders,Agitation,21,0,0,0,Group B
739,Renal and urinary disorders,Acute kidney injury,37,0,0,0,Group B
740,Renal and urinary disorders,Acute kidney injury,24,0,0,0,Group B
741,Renal and urinary disorders,Acute kidney injury,31,0,0,0,Group B
742,Renal and urinary disorders,Acute kidney injury,29,0,0,0,Group B
743,Renal and urinary disorders,Acute kidney injury,39,0,0,0,Group B
744,Renal and urinary disorders,Acute kidney injury,26,0,0,0,Group B
745,Renal and urinary disorders,Acute kidney injury,27,0,0,0,Group B
746,Renal and urinary disorders,Acute kidney injury,38,0,0,0,Group B
747,Renal and urinary disorders,Acute kidney injury,35,0,0,0,Group B
748,Renal and urinary disorders,Acute kidney injury,34,0,0,0,Group B
749,Renal and urinary disorders,Acute kidney injury,21,0,0,0,Group B
750,Renal and urinary disorders,Acute kidney injury,24,0,0,0,Group B
751,Renal and urinary disorders,Acute kidney injury,26,0,0,0,Group B
752,Renal and urinary disorders,Acute kidney injury,39,0,0,0,Group B
753,Renal and urinary disorders,Acute kidney injury,26,0,0,0,Group B
754,Renal and urinary disorders,Acute kidney injury,21,0,0,0,Group B
755,Renal and urinary disorders,Acute kidney injury,35,0,0,0,Group B
756,Renal and urinary disorders,Acute kidney injury,26,0,0,0,Group B
757,Renal and urinary disorders,Acute kidney injury,21,0,0,0,Group B
758,Renal and urinary disorders,Acute kidney injury,24,0,0,0,Group B
759,Renal and urinary disorders,Acute kidney injury,21,0,0,0,Group B
760,Reproductive system and breast disorders,Azoospermia,32,0,0,0,Group B
761,Reproductive system and breast disorders,Azoospermia,42,0,0,0,Group B
762,Reproductive system and breast disorders,Azoospermia,36,0,0,0,Group B
763,Reproductive system and breast disorders,Azoospermia,37,0,0,0,Group B
764,Reproductive system and breast disorders,Azoospermia,24,0,0,0,Group B
765,Reproductive system and breast disorders,Azoospermia,31,0,0,0,Group B
766,Reproductive system and breast disorders,Azoospermia,37,0,0,0,Group B
767,Reproductive system and breast disorders,Azoospermia,36,0,0,0,Group B
768,Reproductive system and breast disorders,Azoospermia,32,0,0,0,Group B
769,Reproductive system and breast disorders,Azoospermia,36,0,0,0,Group B
770,Reproductive system and breast disorders,Azoospermia,31,0,0,0,Group B
771,Reproductive system and breast disorders,Azoospermia,31,0,0,0,Group B
772,Reproductive system and breast disorders,Azoospermia,32,0,0,0,Group B
773,Reproductive system and breast disorders,Azoospermia,31,0,0,0,Group B
774,Reproductive system and breast disorders,Azoospermia,31,0,0,0,Group B
775,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,29,0,0,0,Group B
776,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,39,0,0,0,Group B
777,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,26,0,0,0,Group B
778,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,29,0,0,0,Group B
779,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,29,0,0,0,Group B
780,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,26,0,0,0,Group B
781,Skin and subcutaneous tissue disorders,Alopecia,27,0,0,0,Group B
782,Skin and subcutaneous tissue disorders,Alopecia,38,0,0,0,Group B
783,Skin and subcutaneous tissue disorders,Alopecia,35,0,0,0,Group B
784,Skin and subcutaneous tissue disorders,Alopecia,34,0,0,0,Group B
785,Skin and subcutaneous tissue disorders,Alopecia,21,0,0,0,Group B
786,Skin and subcutaneous tissue disorders,Alopecia,34,0,0,0,Group B
787,Skin and subcutaneous tissue disorders,Alopecia,21,0,0,0,Group B
788,Skin and subcutaneous tissue disorders,Alopecia,35,0,0,0,Group B
789,Skin and subcutaneous tissue disorders,Alopecia,34,0,0,0,Group B
790,Skin and subcutaneous tissue disorders,Alopecia,34,0,0,0,Group B
791,Skin and subcutaneous tissue disorders,Alopecia,35,0,0,0,Group B
792,Social circumstances,Menopause,32,0,0,0,Group B
793,Social circumstances,Menopause,42,0,0,0,Group B
794,Social circumstances,Menopause,36,0,0,0,Group B
795,Social circumstances,Menopause,37,0,0,0,Group B
796,Social circumstances,Menopause,24,0,0,0,Group B
797,Social circumstances,Menopause,31,0,0,0,Group B
798,Social circumstances,Menopause,29,0,0,0,Group B
799,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",39,0,0,0,Group B
800,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",26,0,0,0,Group B
801,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",27,0,0,0,Group B
802,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",38,0,0,0,Group B
803,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",27,0,0,0,Group B
804,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",27,0,0,0,Group B
805,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",26,0,0,0,Group B
806,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",27,0,0,0,Group B
807,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",39,0,0,0,Group B
808,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",38,0,0,0,Group B
809,Vascular disorders,Capillary leak syndrome,35,0,0,0,Group B
810,Vascular disorders,Capillary leak syndrome,34,0,0,0,Group B
811,Vascular disorders,Capillary leak syndrome,21,0,0,0,Group B
812,Vascular disorders,Capillary leak syndrome,32,0,0,0,Group B
813,Vascular disorders,Capillary leak syndrome,42,0,0,0,Group B
814,Blood and lymphatic system disorders,Anemia,22,1,0,0,Group B
815,Blood and lymphatic system disorders,Anemia,35,1,1,0,Group B
816,Blood and lymphatic system disorders,Anemia,28,1,1,0,Group B
817,Blood and lymphatic system disorders,Anemia,26,1,0,0,Group B
818,Blood and lymphatic system disorders,Anemia,40,1,0,0,Group B
819,Blood and lymphatic system disorders,Anemia,33,1,1,0,Group B
820,Blood and lymphatic system disorders,Anemia,27,1,0,0,Group B
821,Blood and lymphatic system disorders,Anemia,28,1,0,0,Group B
822,Blood and lymphatic system disorders,Anemia,40,1,0,0,Group B
823,Blood and lymphatic system disorders,Anemia,22,1,0,0,Group B
824,Blood and lymphatic system disorders,Anemia,26,1,1,0,Group B
825,Blood and lymphatic system disorders,Anemia,28,1,0,0,Group B
826,Blood and lymphatic system disorders,Anemia,35,1,1,0,Group B
827,Blood and lymphatic system disorders,Anemia,40,1,1,0,Group B
828,Blood and lymphatic system disorders,Anemia,28,1,1,0,Group B
829,Blood and lymphatic system disorders,Anemia,33,1,0,0,Group B
830,Cardiac disorders,Acute coronary syndrome,24,1,0,0,Group B
831,Cardiac disorders,Acute coronary syndrome,41,1,1,0,Group B
832,Cardiac disorders,Acute coronary syndrome,29,1,1,0,Group B
833,Cardiac disorders,Acute coronary syndrome,42,1,0,0,Group B
834,Cardiac disorders,Acute coronary syndrome,41,1,1,0,Group B
835,Cardiac disorders,Acute coronary syndrome,24,1,1,0,Group B
836,Cardiac disorders,Acute coronary syndrome,41,1,1,0,Group B
837,Cardiac disorders,Acute coronary syndrome,24,1,0,0,Group B
838,Cardiac disorders,Acute coronary syndrome,41,1,0,0,Group B
839,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",30,1,1,0,Group B
840,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",32,1,0,0,Group B
841,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",22,1,1,0,Group B
842,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",35,1,1,0,Group B
843,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",32,1,0,0,Group B
844,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",22,1,1,0,Group B
845,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",22,1,0,0,Group B
846,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",35,1,1,0,Group B
847,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",30,1,1,0,Group B
848,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",35,1,1,0,Group B
849,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",32,1,0,0,Group B
850,Ear and labyrinth disorders,Ear pain,28,1,1,0,Group B
851,Ear and labyrinth disorders,Ear pain,26,1,0,0,Group B
852,Ear and labyrinth disorders,Ear pain,40,1,0,0,Group B
853,Ear and labyrinth disorders,Ear pain,33,1,0,0,Group B
854,Ear and labyrinth disorders,Ear pain,27,1,1,0,Group B
855,Ear and labyrinth disorders,Ear pain,24,1,0,0,Group B
856,Ear and labyrinth disorders,Ear pain,33,1,1,0,Group B
857,Ear and labyrinth disorders,Ear pain,27,1,0,0,Group B
858,Ear and labyrinth disorders,Ear pain,24,1,1,0,Group B
859,Endocrine disorders,Adrenal insufficiency,33,1,0,1,Group B
860,Endocrine disorders,Adrenal insufficiency,29,1,1,0,Group B
861,Endocrine disorders,Adrenal insufficiency,42,1,0,0,Group B
862,Endocrine disorders,Adrenal insufficiency,30,1,1,0,Group B
863,Endocrine disorders,Adrenal insufficiency,32,1,0,0,Group B
864,Endocrine disorders,Adrenal insufficiency,22,1,0,0,Group B
865,Endocrine disorders,Adrenal insufficiency,35,1,1,0,Group B
866,Endocrine disorders,Adrenal insufficiency,28,1,0,0,Group B
867,Endocrine disorders,Adrenal insufficiency,26,1,0,0,Group B
868,Endocrine disorders,Adrenal insufficiency,40,1,1,0,Group B
869,Endocrine disorders,Adrenal insufficiency,27,1,1,0,Group B
870,Endocrine disorders,Adrenal insufficiency,24,1,1,0,Group B
871,Endocrine disorders,Adrenal insufficiency,28,1,1,0,Group B
872,Endocrine disorders,Adrenal insufficiency,42,1,1,0,Group B
873,Endocrine disorders,Adrenal insufficiency,27,1,0,0,Group B
874,Endocrine disorders,Adrenal insufficiency,42,1,1,0,Group B
875,Endocrine disorders,Adrenal insufficiency,33,1,1,0,Group B
876,Eye disorders,Blurred vision,24,1,1,0,Group B
877,Eye disorders,Blurred vision,41,1,0,0,Group B
878,Eye disorders,Blurred vision,29,1,0,0,Group B
879,Eye disorders,Blurred vision,24,1,0,0,Group B
880,Eye disorders,Blurred vision,41,1,1,0,Group B
881,Eye disorders,Blurred vision,29,1,0,0,Group B
882,Gastrointestinal disorders,Abdominal distension,42,1,1,0,Group B
883,Gastrointestinal disorders,Abdominal distension,30,1,1,0,Group B
884,Gastrointestinal disorders,Abdominal distension,32,1,1,0,Group B
885,Gastrointestinal disorders,Abdominal distension,30,1,1,0,Group B
886,General disorders and administration site conditions,Chills,22,1,1,0,Group B
887,General disorders and administration site conditions,Chills,35,1,1,0,Group B
888,General disorders and administration site conditions,Chills,28,1,1,0,Group B
889,General disorders and administration site conditions,Chills,26,1,1,0,Group B
890,General disorders and administration site conditions,Chills,40,1,1,0,Group B
891,General disorders and administration site conditions,Chills,33,1,1,0,Group B
892,General disorders and administration site conditions,Chills,27,1,1,0,Group B
893,General disorders and administration site conditions,Chills,40,1,1,0,Group B
894,General disorders and administration site conditions,Chills,22,1,1,0,Group B
895,General disorders and administration site conditions,Chills,28,1,1,0,Group B
896,General disorders and administration site conditions,Chills,35,1,1,0,Group B
897,General disorders and administration site conditions,Chills,35,1,1,0,Group B
898,General disorders and administration site conditions,Chills,40,1,1,0,Group B
899,General disorders and administration site conditions,Chills,27,1,0,0,Group B
900,General disorders and administration site conditions,Chills,27,1,0,0,Group B
901,General disorders and administration site conditions,Chills,22,1,1,0,Group B
902,General disorders and administration site conditions,Chills,26,1,0,0,Group B
903,Hepatobiliary disorders,Bile duct stenosis,24,1,1,0,Group B
904,Hepatobiliary disorders,Bile duct stenosis,41,1,0,0,Group B
905,Hepatobiliary disorders,Bile duct stenosis,29,1,1,0,Group B
906,Hepatobiliary disorders,Bile duct stenosis,42,1,0,0,Group B
907,Hepatobiliary disorders,Bile duct stenosis,30,1,0,0,Group B
908,Hepatobiliary disorders,Bile duct stenosis,32,1,0,0,Group B
909,Hepatobiliary disorders,Bile duct stenosis,22,1,1,0,Group B
910,Hepatobiliary disorders,Bile duct stenosis,35,1,0,0,Group B
911,Hepatobiliary disorders,Bile duct stenosis,28,1,1,0,Group B
912,Hepatobiliary disorders,Bile duct stenosis,28,1,0,0,Group B
913,Hepatobiliary disorders,Bile duct stenosis,22,1,1,0,Group B
914,Hepatobiliary disorders,Bile duct stenosis,32,1,0,0,Group B
915,Hepatobiliary disorders,Bile duct stenosis,42,1,1,0,Group B
916,Hepatobiliary disorders,Bile duct stenosis,30,1,1,0,Group B
917,Hepatobiliary disorders,Bile duct stenosis,41,1,1,0,Group B
918,Hepatobiliary disorders,Bile duct stenosis,42,1,0,0,Group B
919,Immune system disorders,Allergic reaction,26,1,1,0,Group B
920,Immune system disorders,Allergic reaction,40,1,0,0,Group B
921,Immune system disorders,Allergic reaction,33,1,0,0,Group B
922,Immune system disorders,Allergic reaction,27,1,1,0,Group B
923,Immune system disorders,Allergic reaction,24,1,1,0,Group B
924,Immune system disorders,Allergic reaction,41,1,0,0,Group B
925,Immune system disorders,Allergic reaction,29,1,0,0,Group B
926,Immune system disorders,Allergic reaction,42,1,0,0,Group B
927,Immune system disorders,Allergic reaction,29,1,0,0,Group B
928,Immune system disorders,Allergic reaction,29,1,0,0,Group B
929,Immune system disorders,Allergic reaction,40,1,1,0,Group B
930,Immune system disorders,Allergic reaction,41,1,0,0,Group B
931,Immune system disorders,Allergic reaction,41,1,0,0,Group B
932,Infections and infestations,Abdominal infection,30,1,0,0,Group B
933,Infections and infestations,Abdominal infection,32,1,0,0,Group B
934,Infections and infestations,Abdominal infection,22,1,0,0,Group B
935,Infections and infestations,Abdominal infection,35,1,0,0,Group B
936,Infections and infestations,Abdominal infection,28,1,1,0,Group B
937,Infections and infestations,Abdominal infection,28,1,0,0,Group B
938,Infections and infestations,Abdominal infection,22,1,0,0,Group B
939,Infections and infestations,Abdominal infection,35,1,0,0,Group B
940,"Injury, poisoning and procedural complications",Ankle fracture,26,1,1,0,Group B
941,"Injury, poisoning and procedural complications",Ankle fracture,40,1,1,0,Group B
942,"Injury, poisoning and procedural complications",Ankle fracture,33,1,0,0,Group B
943,"Injury, poisoning and procedural complications",Ankle fracture,27,1,1,0,Group B
944,"Injury, poisoning and procedural complications",Ankle fracture,24,1,0,0,Group B
945,"Injury, poisoning and procedural complications",Ankle fracture,41,1,0,0,Group B
946,"Injury, poisoning and procedural complications",Ankle fracture,27,1,1,0,Group B
947,"Injury, poisoning and procedural complications",Ankle fracture,24,1,0,0,Group B
948,"Injury, poisoning and procedural complications",Ankle fracture,40,1,0,0,Group B
949,Investigations,Activated partial thromboplastin time prolonged,29,1,0,0,Group B
950,Investigations,Activated partial thromboplastin time prolonged,42,1,1,0,Group B
951,Investigations,Activated partial thromboplastin time prolonged,30,1,0,0,Group B
952,Investigations,Activated partial thromboplastin time prolonged,32,1,1,0,Group B
953,Investigations,Activated partial thromboplastin time prolonged,22,1,1,0,Group B
954,Investigations,Activated partial thromboplastin time prolonged,35,1,0,0,Group B
955,Investigations,Activated partial thromboplastin time prolonged,30,1,1,0,Group B
956,Investigations,Activated partial thromboplastin time prolonged,35,1,1,0,Group B
957,Investigations,Activated partial thromboplastin time prolonged,29,1,0,0,Group B
958,Investigations,Activated partial thromboplastin time prolonged,29,1,0,0,Group B
959,Investigations,Activated partial thromboplastin time prolonged,22,1,1,0,Group B
960,Metabolism and nutrition disorders,Acidosis,30,1,0,1,Group B
961,Metabolism and nutrition disorders,Acidosis,22,1,0,1,Group B
962,Metabolism and nutrition disorders,Acidosis,26,1,0,0,Group B
963,Metabolism and nutrition disorders,Acidosis,40,1,1,0,Group B
964,Metabolism and nutrition disorders,Acidosis,33,1,0,0,Group B
965,Metabolism and nutrition disorders,Acidosis,33,1,0,0,Group B
966,Metabolism and nutrition disorders,Acidosis,30,1,0,0,Group B
967,Metabolism and nutrition disorders,Acidosis,30,1,0,0,Group B
968,Metabolism and nutrition disorders,Acidosis,30,1,1,0,Group B
969,Metabolism and nutrition disorders,Acidosis,26,1,0,0,Group B
970,Metabolism and nutrition disorders,Acidosis,22,1,0,0,Group B
971,Metabolism and nutrition disorders,Acidosis,33,1,1,0,Group B
972,Metabolism and nutrition disorders,Acidosis,33,1,0,0,Group B
973,Metabolism and nutrition disorders,Acidosis,22,1,0,0,Group B
974,Metabolism and nutrition disorders,Acidosis,26,1,0,0,Group B
975,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,33,1,0,0,Group B
976,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,27,1,1,0,Group B
977,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,24,1,0,0,Group B
978,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,41,1,0,0,Group B
979,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,41,1,0,0,Group B
980,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,24,1,1,0,Group B
981,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,24,1,0,0,Group B
982,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,27,1,0,0,Group B
983,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,27,1,1,0,Group B
984,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,33,1,0,0,Group B
985,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,24,1,1,1,Group B
986,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,29,1,1,1,Group B
987,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,30,1,1,0,Group B
988,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,32,1,1,0,Group B
989,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,32,1,1,0,Group B
990,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,32,1,1,0,Group B
991,Nervous system disorders,Abducens nerve disorder,30,1,0,0,Group B
992,Nervous system disorders,Abducens nerve disorder,32,1,1,0,Group B
993,Nervous system disorders,Abducens nerve disorder,22,1,0,0,Group B
994,Nervous system disorders,Abducens nerve disorder,35,1,1,0,Group B
995,Nervous system disorders,Abducens nerve disorder,28,1,0,0,Group B
996,Nervous system disorders,Abducens nerve disorder,26,1,1,0,Group B
997,Nervous system disorders,Abducens nerve disorder,28,1,0,0,Group B
998,Nervous system disorders,Abducens nerve disorder,32,1,1,0,Group B
999,"Pregnancy, puerperium and perinatal conditions",Fetal death,40,1,1,0,Group B
1000,"Pregnancy, puerperium and perinatal conditions",Fetal death,33,1,1,0,Group B
1001,"Pregnancy, puerperium and perinatal conditions",Fetal death,27,1,1,0,Group B
1002,"Pregnancy, puerperium and perinatal conditions",Fetal death,24,1,1,0,Group B
1003,"Pregnancy, puerperium and perinatal conditions",Fetal death,41,1,1,0,Group B
1004,"Pregnancy, puerperium and perinatal conditions",Fetal death,33,1,1,0,Group B
1005,"Pregnancy, puerperium and perinatal conditions",Fetal death,33,1,1,0,Group B
1006,"Pregnancy, puerperium and perinatal conditions",Fetal death,24,1,1,0,Group B
1007,"Pregnancy, puerperium and perinatal conditions",Fetal death,27,1,1,0,Group B
1008,"Pregnancy, puerperium and perinatal conditions",Fetal death,40,1,0,0,Group B
1009,"Pregnancy, puerperium and perinatal conditions",Fetal death,27,1,1,0,Group B
1010,"Pregnancy, puerperium and perinatal conditions",Fetal death,33,1,1,0,Group B
1011,"Pregnancy, puerperium and perinatal conditions",Fetal death,33,1,0,0,Group B
1012,"Pregnancy, puerperium and perinatal conditions",Fetal death,40,1,0,0,Group B
1013,Psychiatric disorders,Agitation,29,1,1,0,Group B
1014,Psychiatric disorders,Agitation,42,1,0,0,Group B
1015,Psychiatric disorders,Agitation,30,1,1,0,Group B
1016,Psychiatric disorders,Agitation,32,1,0,0,Group B
1017,Psychiatric disorders,Agitation,22,1,0,0,Group B
1018,Psychiatric disorders,Agitation,35,1,1,0,Group B
1019,Psychiatric disorders,Agitation,28,1,0,0,Group B
1020,Psychiatric disorders,Agitation,26,1,0,0,Group B
1021,Psychiatric disorders,Agitation,40,1,1,0,Group B
1022,Psychiatric disorders,Agitation,33,1,1,0,Group B
1023,Psychiatric disorders,Agitation,32,1,1,0,Group B
1024,Psychiatric disorders,Agitation,40,1,1,0,Group B
1025,Psychiatric disorders,Agitation,35,1,1,0,Group B
1026,Psychiatric disorders,Agitation,33,1,0,0,Group B
1027,Psychiatric disorders,Agitation,35,1,1,0,Group B
1028,Renal and urinary disorders,Acute kidney injury,27,1,0,0,Group B
1029,Renal and urinary disorders,Acute kidney injury,24,1,1,0,Group B
1030,Renal and urinary disorders,Acute kidney injury,41,1,0,0,Group B
1031,Renal and urinary disorders,Acute kidney injury,29,1,0,0,Group B
1032,Renal and urinary disorders,Acute kidney injury,42,1,0,0,Group B
1033,Renal and urinary disorders,Acute kidney injury,29,1,0,0,Group B
1034,Renal and urinary disorders,Acute kidney injury,42,1,0,0,Group B
1035,Renal and urinary disorders,Acute kidney injury,29,1,1,0,Group B
1036,Renal and urinary disorders,Acute kidney injury,24,1,0,0,Group B
1037,Reproductive system and breast disorders,Azoospermia,30,1,0,0,Group B
1038,Reproductive system and breast disorders,Azoospermia,32,1,1,0,Group B
1039,Reproductive system and breast disorders,Azoospermia,22,1,0,0,Group B
1040,Reproductive system and breast disorders,Azoospermia,22,1,0,0,Group B
1041,Reproductive system and breast disorders,Azoospermia,30,1,1,0,Group B
1042,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,35,1,0,0,Group B
1043,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,28,1,0,0,Group B
1044,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,26,1,1,0,Group B
1045,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,40,1,0,0,Group B
1046,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,33,1,1,0,Group B
1047,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,27,1,0,0,Group B
1048,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,24,1,1,0,Group B
1049,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,41,1,1,0,Group B
1050,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,29,1,1,0,Group B
1051,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,42,1,1,0,Group B
1052,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,30,1,1,0,Group B
1053,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,32,1,1,0,Group B
1054,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,32,1,1,0,Group B
1055,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,30,1,0,0,Group B
1056,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,42,1,0,0,Group B
1057,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,29,1,1,0,Group B
1058,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,41,1,0,0,Group B
1059,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,41,1,0,0,Group B
1060,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,24,1,0,0,Group B
1061,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,32,1,1,0,Group B
1062,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,29,1,0,0,Group B
1063,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,40,1,1,0,Group B
1064,Skin and subcutaneous tissue disorders,Alopecia,22,1,1,0,Group B
1065,Skin and subcutaneous tissue disorders,Alopecia,35,1,1,0,Group B
1066,Skin and subcutaneous tissue disorders,Alopecia,28,1,1,0,Group B
1067,Skin and subcutaneous tissue disorders,Alopecia,26,1,0,0,Group B
1068,Skin and subcutaneous tissue disorders,Alopecia,40,1,1,0,Group B
1069,Skin and subcutaneous tissue disorders,Alopecia,33,1,0,0,Group B
1070,Skin and subcutaneous tissue disorders,Alopecia,27,1,0,0,Group B
1071,Skin and subcutaneous tissue disorders,Alopecia,24,1,0,0,Group B
1072,Skin and subcutaneous tissue disorders,Alopecia,26,1,1,0,Group B
1073,Skin and subcutaneous tissue disorders,Alopecia,22,1,1,0,Group B
1074,Social circumstances,Menopause,41,1,0,0,Group B
1075,Social circumstances,Menopause,29,1,0,0,Group B
1076,Social circumstances,Menopause,42,1,0,0,Group B
1077,Social circumstances,Menopause,30,1,0,0,Group B
1078,Social circumstances,Menopause,32,1,1,0,Group B
1079,Social circumstances,Menopause,22,1,1,0,Group B
1080,Social circumstances,Menopause,29,1,0,0,Group B
1081,Social circumstances,Menopause,41,1,1,0,Group B
1082,Social circumstances,Menopause,42,1,0,0,Group B
1083,Social circumstances,Menopause,32,1,1,0,Group B
1084,Social circumstances,Menopause,42,1,0,0,Group B
1085,Social circumstances,Menopause,29,1,1,0,Group B
1086,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",35,1,1,0,Group B
1087,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",28,1,1,0,Group B
1088,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",26,1,0,0,Group B
1089,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",40,1,0,0,Group B
1090,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",33,1,0,0,Group B
1091,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",27,1,1,0,Group B
1092,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",24,1,1,0,Group B
1093,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",41,1,1,0,Group B
1094,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",29,1,1,0,Group B
1095,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",29,1,0,0,Group B
1096,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",27,1,0,0,Group B
1097,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",26,1,1,0,Group B
1098,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",41,1,0,0,Group B
1099,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",33,1,1,0,Group B
1100,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",27,1,0,0,Group B
1101,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",29,1,1,0,Group B
1102,Vascular disorders,Capillary leak syndrome,40,1,1,1,Group B
1103,Vascular disorders,Capillary leak syndrome,30,1,0,0,Group B
1104,Vascular disorders,Capillary leak syndrome,32,1,0,0,Group B
1105,Vascular disorders,Capillary leak syndrome,22,1,0,0,Group B
1106,Vascular disorders,Capillary leak syndrome,35,1,0,0,Group B
1107,Vascular disorders,Capillary leak syndrome,28,1,0,0,Group B
1108,Vascular disorders,Capillary leak syndrome,35,1,0,0,Group B
1109,Vascular disorders,Capillary leak syndrome,32,1,0,0,Group B
1110,Vascular disorders,Capillary leak syndrome,35,1,0,0,Group B
1111,Vascular disorders,Capillary leak syndrome,32,1,0,0,Group B
1112,Vascular disorders,Capillary leak syndrome,28,1,0,0,Group B
1113,Blood and lymphatic system disorders,Anemia,47,0,0,0,Group C
1114,Blood and lymphatic system disorders,Anemia,45,0,0,0,Group C
1115,Blood and lymphatic system disorders,Anemia,60,0,0,0,Group C
1116,Blood and lymphatic system disorders,Anemia,54,0,0,0,Group C
1117,Blood and lymphatic system disorders,Anemia,55,0,0,0,Group C
1118,Blood and lymphatic system disorders,Anemia,55,0,0,0,Group C
1119,Blood and lymphatic system disorders,Anemia,47,0,0,0,Group C
1120,Blood and lymphatic system disorders,Anemia,54,0,0,0,Group C
1121,Blood and lymphatic system disorders,Anemia,60,0,0,0,Group C
1122,Blood and lymphatic system disorders,Anemia,47,0,0,0,Group C
1123,Blood and lymphatic system disorders,Anemia,60,0,0,0,Group C
1124,Cardiac disorders,Acute coronary syndrome,49,0,0,0,Group C
1125,Cardiac disorders,Acute coronary syndrome,53,0,0,0,Group C
1126,Cardiac disorders,Acute coronary syndrome,56,0,0,0,Group C
1127,Cardiac disorders,Acute coronary syndrome,56,0,0,0,Group C
1128,Cardiac disorders,Acute coronary syndrome,49,0,0,0,Group C
1129,Cardiac disorders,Acute coronary syndrome,56,0,0,0,Group C
1130,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",44,0,0,0,Group C
1131,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",46,0,0,0,Group C
1132,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",43,0,0,0,Group C
1133,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",47,0,0,0,Group C
1134,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",45,0,0,0,Group C
1135,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",60,0,0,0,Group C
1136,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",54,0,0,0,Group C
1137,Ear and labyrinth disorders,Ear pain,55,0,0,0,Group C
1138,Ear and labyrinth disorders,Ear pain,49,0,0,0,Group C
1139,Ear and labyrinth disorders,Ear pain,53,0,0,0,Group C
1140,Ear and labyrinth disorders,Ear pain,56,0,0,0,Group C
1141,Ear and labyrinth disorders,Ear pain,44,0,0,0,Group C
1142,Ear and labyrinth disorders,Ear pain,55,0,0,0,Group C
1143,Ear and labyrinth disorders,Ear pain,53,0,0,0,Group C
1144,Ear and labyrinth disorders,Ear pain,49,0,0,0,Group C
1145,Endocrine disorders,Adrenal insufficiency,46,0,0,0,Group C
1146,Endocrine disorders,Adrenal insufficiency,43,0,0,0,Group C
1147,Endocrine disorders,Adrenal insufficiency,47,0,0,0,Group C
1148,Endocrine disorders,Adrenal insufficiency,45,0,0,0,Group C
1149,Eye disorders,Blurred vision,60,0,0,0,Group C
1150,Eye disorders,Blurred vision,54,0,0,0,Group C
1151,Eye disorders,Blurred vision,55,0,0,0,Group C
1152,Eye disorders,Blurred vision,49,0,0,0,Group C
1153,Eye disorders,Blurred vision,53,0,0,0,Group C
1154,Eye disorders,Blurred vision,56,0,0,0,Group C
1155,Eye disorders,Blurred vision,44,0,0,0,Group C
1156,Eye disorders,Blurred vision,46,0,0,0,Group C
1157,Eye disorders,Blurred vision,46,0,0,0,Group C
1158,Eye disorders,Blurred vision,46,0,0,0,Group C
1159,Eye disorders,Blurred vision,49,0,0,0,Group C
1160,Eye disorders,Blurred vision,56,0,0,0,Group C
1161,Eye disorders,Blurred vision,55,0,0,0,Group C
1162,Eye disorders,Blurred vision,56,0,0,0,Group C
1163,Eye disorders,Blurred vision,60,0,0,0,Group C
1164,Eye disorders,Blurred vision,49,0,0,0,Group C
1165,Gastrointestinal disorders,Abdominal distension,43,0,0,0,Group C
1166,Gastrointestinal disorders,Abdominal distension,47,0,0,0,Group C
1167,Gastrointestinal disorders,Abdominal distension,45,0,0,0,Group C
1168,Gastrointestinal disorders,Abdominal distension,60,0,0,0,Group C
1169,Gastrointestinal disorders,Abdominal distension,54,0,0,0,Group C
1170,Gastrointestinal disorders,Abdominal distension,55,0,0,0,Group C
1171,Gastrointestinal disorders,Abdominal distension,49,0,0,0,Group C
1172,Gastrointestinal disorders,Abdominal distension,49,0,0,0,Group C
1173,Gastrointestinal disorders,Abdominal distension,54,0,0,0,Group C
1174,Gastrointestinal disorders,Abdominal distension,45,0,0,0,Group C
1175,Gastrointestinal disorders,Abdominal distension,55,0,0,0,Group C
1176,Gastrointestinal disorders,Abdominal distension,43,0,0,0,Group C
1177,Gastrointestinal disorders,Abdominal distension,54,0,0,0,Group C
1178,General disorders and administration site conditions,Chills,53,0,0,0,Group C
1179,General disorders and administration site conditions,Chills,56,0,0,0,Group C
1180,General disorders and administration site conditions,Chills,44,0,0,0,Group C
1181,General disorders and administration site conditions,Chills,46,0,0,0,Group C
1182,General disorders and administration site conditions,Chills,43,0,0,0,Group C
1183,General disorders and administration site conditions,Chills,47,0,0,0,Group C
1184,General disorders and administration site conditions,Chills,45,0,0,0,Group C
1185,General disorders and administration site conditions,Chills,60,0,0,0,Group C
1186,General disorders and administration site conditions,Chills,54,0,0,0,Group C
1187,General disorders and administration site conditions,Chills,55,0,0,0,Group C
1188,General disorders and administration site conditions,Chills,44,0,0,0,Group C
1189,General disorders and administration site conditions,Chills,54,0,0,0,Group C
1190,General disorders and administration site conditions,Chills,47,0,0,0,Group C
1191,General disorders and administration site conditions,Chills,44,0,0,0,Group C
1192,General disorders and administration site conditions,Chills,44,0,0,0,Group C
1193,Hepatobiliary disorders,Bile duct stenosis,49,0,0,0,Group C
1194,Hepatobiliary disorders,Bile duct stenosis,53,0,0,0,Group C
1195,Hepatobiliary disorders,Bile duct stenosis,56,0,0,0,Group C
1196,Hepatobiliary disorders,Bile duct stenosis,53,0,0,0,Group C
1197,Hepatobiliary disorders,Bile duct stenosis,53,0,0,0,Group C
1198,Hepatobiliary disorders,Bile duct stenosis,53,0,0,0,Group C
1199,Hepatobiliary disorders,Bile duct stenosis,53,0,0,0,Group C
1200,Hepatobiliary disorders,Bile duct stenosis,49,0,0,0,Group C
1201,Hepatobiliary disorders,Bile duct stenosis,49,0,0,0,Group C
1202,Immune system disorders,Allergic reaction,44,0,0,0,Group C
1203,Immune system disorders,Allergic reaction,46,0,0,0,Group C
1204,Immune system disorders,Allergic reaction,43,0,0,0,Group C
1205,Immune system disorders,Allergic reaction,44,0,0,0,Group C
1206,Immune system disorders,Allergic reaction,44,0,0,0,Group C
1207,Immune system disorders,Allergic reaction,44,0,0,0,Group C
1208,Immune system disorders,Allergic reaction,46,0,0,0,Group C
1209,Immune system disorders,Allergic reaction,46,0,0,0,Group C
1210,Infections and infestations,Abdominal infection,47,0,0,0,Group C
1211,Infections and infestations,Abdominal infection,45,0,0,0,Group C
1212,Infections and infestations,Abdominal infection,60,0,0,0,Group C
1213,Infections and infestations,Abdominal infection,60,0,0,0,Group C
1214,"Injury, poisoning and procedural complications",Ankle fracture,54,0,0,0,Group C
1215,"Injury, poisoning and procedural complications",Ankle fracture,55,0,0,0,Group C
1216,"Injury, poisoning and procedural complications",Ankle fracture,49,0,0,0,Group C
1217,"Injury, poisoning and procedural complications",Ankle fracture,53,0,0,0,Group C
1218,"Injury, poisoning and procedural complications",Ankle fracture,56,0,0,0,Group C
1219,"Injury, poisoning and procedural complications",Ankle fracture,44,0,0,0,Group C
1220,"Injury, poisoning and procedural complications",Ankle fracture,46,0,0,0,Group C
1221,"Injury, poisoning and procedural complications",Ankle fracture,43,0,0,0,Group C
1222,"Injury, poisoning and procedural complications",Ankle fracture,56,0,0,0,Group C
1223,"Injury, poisoning and procedural complications",Ankle fracture,46,0,0,0,Group C
1224,"Injury, poisoning and procedural complications",Ankle fracture,46,0,0,0,Group C
1225,"Injury, poisoning and procedural complications",Ankle fracture,56,0,0,0,Group C
1226,"Injury, poisoning and procedural complications",Ankle fracture,44,0,0,0,Group C
1227,"Injury, poisoning and procedural complications",Ankle fracture,53,0,0,0,Group C
1228,"Injury, poisoning and procedural complications",Ankle fracture,53,0,0,0,Group C
1229,"Injury, poisoning and procedural complications",Ankle fracture,49,0,0,0,Group C
1230,"Injury, poisoning and procedural complications",Ankle fracture,53,0,0,0,Group C
1231,Investigations,Activated partial thromboplastin time prolonged,47,0,0,0,Group C
1232,Investigations,Activated partial thromboplastin time prolonged,45,0,0,0,Group C
1233,Investigations,Activated partial thromboplastin time prolonged,45,0,0,0,Group C
1234,Investigations,Activated partial thromboplastin time prolonged,45,0,0,0,Group C
1235,Investigations,Activated partial thromboplastin time prolonged,45,0,0,0,Group C
1236,Investigations,Activated partial thromboplastin time prolonged,47,0,0,0,Group C
1237,Investigations,Activated partial thromboplastin time prolonged,47,0,0,0,Group C
1238,Metabolism and nutrition disorders,Acidosis,60,0,0,0,Group C
1239,Metabolism and nutrition disorders,Acidosis,54,0,0,0,Group C
1240,Metabolism and nutrition disorders,Acidosis,55,0,0,0,Group C
1241,Metabolism and nutrition disorders,Acidosis,49,0,0,0,Group C
1242,Metabolism and nutrition disorders,Acidosis,53,0,0,0,Group C
1243,Metabolism and nutrition disorders,Acidosis,56,0,0,0,Group C
1244,Metabolism and nutrition disorders,Acidosis,44,0,0,0,Group C
1245,Metabolism and nutrition disorders,Acidosis,46,0,0,0,Group C
1246,Metabolism and nutrition disorders,Acidosis,43,0,0,0,Group C
1247,Metabolism and nutrition disorders,Acidosis,47,0,0,0,Group C
1248,Metabolism and nutrition disorders,Acidosis,45,0,0,0,Group C
1249,Metabolism and nutrition disorders,Acidosis,56,0,0,0,Group C
1250,Metabolism and nutrition disorders,Acidosis,46,0,0,0,Group C
1251,Metabolism and nutrition disorders,Acidosis,45,0,0,0,Group C
1252,Metabolism and nutrition disorders,Acidosis,47,0,0,0,Group C
1253,Metabolism and nutrition disorders,Acidosis,55,0,0,0,Group C
1254,Metabolism and nutrition disorders,Acidosis,49,0,0,0,Group C
1255,Metabolism and nutrition disorders,Acidosis,53,0,0,0,Group C
1256,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,60,0,0,0,Group C
1257,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,54,0,0,0,Group C
1258,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,55,0,0,0,Group C
1259,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,49,0,0,0,Group C
1260,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,53,0,0,0,Group C
1261,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,56,0,0,0,Group C
1262,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,44,0,0,0,Group C
1263,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,46,0,0,0,Group C
1264,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,43,0,0,0,Group C
1265,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,44,0,0,0,Group C
1266,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,55,0,0,0,Group C
1267,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,47,0,0,0,Group C
1268,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,45,0,0,0,Group C
1269,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,60,0,0,0,Group C
1270,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,54,0,0,0,Group C
1271,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,55,0,0,0,Group C
1272,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,60,0,0,0,Group C
1273,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,45,0,0,0,Group C
1274,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,60,0,0,0,Group C
1275,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,54,0,0,0,Group C
1276,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,54,0,0,0,Group C
1277,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,45,0,0,0,Group C
1278,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,60,0,0,0,Group C
1279,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,54,0,0,0,Group C
1280,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,60,0,0,0,Group C
1281,Nervous system disorders,Abducens nerve disorder,49,0,0,0,Group C
1282,Nervous system disorders,Abducens nerve disorder,53,0,0,0,Group C
1283,Nervous system disorders,Abducens nerve disorder,56,0,0,0,Group C
1284,Nervous system disorders,Abducens nerve disorder,44,0,0,0,Group C
1285,Nervous system disorders,Abducens nerve disorder,46,0,0,0,Group C
1286,Nervous system disorders,Abducens nerve disorder,43,0,0,0,Group C
1287,Nervous system disorders,Abducens nerve disorder,47,0,0,0,Group C
1288,Nervous system disorders,Abducens nerve disorder,45,0,0,0,Group C
1289,Nervous system disorders,Abducens nerve disorder,44,0,0,0,Group C
1290,Nervous system disorders,Abducens nerve disorder,47,0,0,0,Group C
1291,Nervous system disorders,Abducens nerve disorder,46,0,0,0,Group C
1292,Nervous system disorders,Abducens nerve disorder,43,0,0,0,Group C
1293,Nervous system disorders,Abducens nerve disorder,43,0,0,0,Group C
1294,Nervous system disorders,Abducens nerve disorder,46,0,0,0,Group C
1295,Nervous system disorders,Abducens nerve disorder,43,0,0,0,Group C
1296,Nervous system disorders,Abducens nerve disorder,47,0,0,0,Group C
1297,Nervous system disorders,Abducens nerve disorder,56,0,0,0,Group C
1298,Nervous system disorders,Abducens nerve disorder,49,0,0,0,Group C
1299,"Pregnancy, puerperium and perinatal conditions",Fetal death,60,0,0,0,Group C
1300,"Pregnancy, puerperium and perinatal conditions",Fetal death,54,0,0,0,Group C
1301,"Pregnancy, puerperium and perinatal conditions",Fetal death,55,0,0,0,Group C
1302,"Pregnancy, puerperium and perinatal conditions",Fetal death,49,0,0,0,Group C
1303,"Pregnancy, puerperium and perinatal conditions",Fetal death,53,0,0,0,Group C
1304,"Pregnancy, puerperium and perinatal conditions",Fetal death,56,0,0,0,Group C
1305,"Pregnancy, puerperium and perinatal conditions",Fetal death,55,0,0,0,Group C
1306,Psychiatric disorders,Agitation,44,0,0,0,Group C
1307,Psychiatric disorders,Agitation,46,0,0,0,Group C
1308,Psychiatric disorders,Agitation,43,0,0,0,Group C
1309,Psychiatric disorders,Agitation,47,0,0,0,Group C
1310,Psychiatric disorders,Agitation,45,0,0,0,Group C
1311,Psychiatric disorders,Agitation,60,0,0,0,Group C
1312,Psychiatric disorders,Agitation,54,0,0,0,Group C
1313,Psychiatric disorders,Agitation,44,0,0,0,Group C
1314,Renal and urinary disorders,Acute kidney injury,55,0,0,0,Group C
1315,Renal and urinary disorders,Acute kidney injury,49,0,0,0,Group C
1316,Renal and urinary disorders,Acute kidney injury,53,0,0,0,Group C
1317,Renal and urinary disorders,Acute kidney injury,56,0,0,0,Group C
1318,Renal and urinary disorders,Acute kidney injury,44,0,0,0,Group C
1319,Renal and urinary disorders,Acute kidney injury,49,0,0,0,Group C
1320,Renal and urinary disorders,Acute kidney injury,49,0,0,0,Group C
1321,Renal and urinary disorders,Acute kidney injury,56,0,0,0,Group C
1322,Renal and urinary disorders,Acute kidney injury,53,0,0,0,Group C
1323,Renal and urinary disorders,Acute kidney injury,44,0,0,0,Group C
1324,Renal and urinary disorders,Acute kidney injury,53,0,0,0,Group C
1325,Reproductive system and breast disorders,Azoospermia,46,0,0,0,Group C
1326,Reproductive system and breast disorders,Azoospermia,43,0,0,0,Group C
1327,Reproductive system and breast disorders,Azoospermia,47,0,0,0,Group C
1328,Reproductive system and breast disorders,Azoospermia,45,0,0,0,Group C
1329,Reproductive system and breast disorders,Azoospermia,60,0,0,0,Group C
1330,Reproductive system and breast disorders,Azoospermia,54,0,0,0,Group C
1331,Reproductive system and breast disorders,Azoospermia,54,0,0,0,Group C
1332,Reproductive system and breast disorders,Azoospermia,54,0,0,0,Group C
1333,Reproductive system and breast disorders,Azoospermia,47,0,0,0,Group C
1334,Reproductive system and breast disorders,Azoospermia,46,0,0,0,Group C
1335,Reproductive system and breast disorders,Azoospermia,45,0,0,0,Group C
1336,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,55,0,0,0,Group C
1337,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,49,0,0,0,Group C
1338,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,53,0,0,0,Group C
1339,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,56,0,0,0,Group C
1340,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,44,0,0,0,Group C
1341,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,46,0,0,0,Group C
1342,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,43,0,0,0,Group C
1343,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,47,0,0,0,Group C
1344,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,53,0,0,0,Group C
1345,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,49,0,0,0,Group C
1346,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,55,0,0,0,Group C
1347,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,47,0,0,0,Group C
1348,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,47,0,0,0,Group C
1349,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,43,0,0,0,Group C
1350,Skin and subcutaneous tissue disorders,Alopecia,45,0,0,0,Group C
1351,Skin and subcutaneous tissue disorders,Alopecia,60,0,0,0,Group C
1352,Skin and subcutaneous tissue disorders,Alopecia,54,0,0,0,Group C
1353,Skin and subcutaneous tissue disorders,Alopecia,55,0,0,0,Group C
1354,Skin and subcutaneous tissue disorders,Alopecia,49,0,0,0,Group C
1355,Skin and subcutaneous tissue disorders,Alopecia,49,0,0,0,Group C
1356,Skin and subcutaneous tissue disorders,Alopecia,45,0,0,0,Group C
1357,Skin and subcutaneous tissue disorders,Alopecia,49,0,0,0,Group C
1358,Skin and subcutaneous tissue disorders,Alopecia,54,0,0,0,Group C
1359,Skin and subcutaneous tissue disorders,Alopecia,55,0,0,0,Group C
1360,Skin and subcutaneous tissue disorders,Alopecia,60,0,0,0,Group C
1361,Skin and subcutaneous tissue disorders,Alopecia,54,0,0,0,Group C
1362,Skin and subcutaneous tissue disorders,Alopecia,60,0,0,0,Group C
1363,Skin and subcutaneous tissue disorders,Alopecia,55,0,0,0,Group C
1364,Skin and subcutaneous tissue disorders,Alopecia,49,0,0,0,Group C
1365,Social circumstances,Menopause,53,0,0,0,Group C
1366,Social circumstances,Menopause,53,0,0,0,Group C
1367,Social circumstances,Menopause,53,0,0,0,Group C
1368,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",56,0,0,0,Group C
1369,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",44,0,0,0,Group C
1370,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",46,0,0,0,Group C
1371,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",43,0,0,0,Group C
1372,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",44,0,0,0,Group C
1373,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",44,0,0,0,Group C
1374,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",43,0,0,0,Group C
1375,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",56,0,0,0,Group C
1376,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",56,0,0,0,Group C
1377,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",46,0,0,0,Group C
1378,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",44,0,0,0,Group C
1379,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",46,0,0,0,Group C
1380,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",44,0,0,0,Group C
1381,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",56,0,0,0,Group C
1382,Vascular disorders,Capillary leak syndrome,47,0,0,0,Group C
1383,Vascular disorders,Capillary leak syndrome,45,0,0,0,Group C
1384,Vascular disorders,Capillary leak syndrome,60,0,0,0,Group C
1385,Vascular disorders,Capillary leak syndrome,54,0,0,0,Group C
1386,Vascular disorders,Capillary leak syndrome,55,0,0,0,Group C
1387,Vascular disorders,Capillary leak syndrome,49,0,0,0,Group C
1388,Vascular disorders,Capillary leak syndrome,53,0,0,0,Group C
1389,Vascular disorders,Capillary leak syndrome,49,0,0,0,Group C
1390,Blood and lymphatic system disorders,Anemia,53,1,0,0,Group C
1391,Blood and lymphatic system disorders,Anemia,56,1,0,0,Group C
1392,Blood and lymphatic system disorders,Anemia,52,1,0,0,Group C
1393,Blood and lymphatic system disorders,Anemia,52,1,0,0,Group C
1394,Blood and lymphatic system disorders,Anemia,52,1,1,0,Group C
1395,Blood and lymphatic system disorders,Anemia,53,1,0,0,Group C
1396,Blood and lymphatic system disorders,Anemia,53,1,0,0,Group C
1397,Blood and lymphatic system disorders,Anemia,52,1,0,0,Group C
1398,Blood and lymphatic system disorders,Anemia,56,1,0,0,Group C
1399,Blood and lymphatic system disorders,Anemia,53,1,0,0,Group C
1400,Blood and lymphatic system disorders,Anemia,53,1,0,0,Group C
1401,Blood and lymphatic system disorders,Anemia,53,1,0,0,Group C
1402,Blood and lymphatic system disorders,Anemia,56,1,0,0,Group C
1403,Cardiac disorders,Acute coronary syndrome,55,1,0,0,Group C
1404,Cardiac disorders,Acute coronary syndrome,54,1,1,0,Group C
1405,Cardiac disorders,Acute coronary syndrome,50,1,1,0,Group C
1406,Cardiac disorders,Acute coronary syndrome,44,1,1,0,Group C
1407,Cardiac disorders,Acute coronary syndrome,46,1,0,0,Group C
1408,Cardiac disorders,Acute coronary syndrome,49,1,1,0,Group C
1409,Cardiac disorders,Acute coronary syndrome,53,1,0,0,Group C
1410,Cardiac disorders,Acute coronary syndrome,56,1,1,0,Group C
1411,Cardiac disorders,Acute coronary syndrome,52,1,1,0,Group C
1412,Cardiac disorders,Acute coronary syndrome,56,1,1,0,Group C
1413,Cardiac disorders,Acute coronary syndrome,46,1,1,0,Group C
1414,Cardiac disorders,Acute coronary syndrome,50,1,1,0,Group C
1415,Cardiac disorders,Acute coronary syndrome,49,1,1,0,Group C
1416,Cardiac disorders,Acute coronary syndrome,54,1,0,0,Group C
1417,Cardiac disorders,Acute coronary syndrome,54,1,0,0,Group C
1418,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",53,1,0,1,Group C
1419,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",54,1,1,0,Group C
1420,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",50,1,1,0,Group C
1421,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",44,1,0,0,Group C
1422,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",46,1,1,0,Group C
1423,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",49,1,1,0,Group C
1424,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",56,1,1,0,Group C
1425,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",52,1,1,0,Group C
1426,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",55,1,1,0,Group C
1427,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",46,1,1,0,Group C
1428,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",55,1,0,0,Group C
1429,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",44,1,0,0,Group C
1430,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",55,1,1,0,Group C
1431,"Congenital, familial and genetic disorders","Congenital, familial and genetic disorders - Other, specify",53,1,0,0,Group C
1432,Ear and labyrinth disorders,Ear pain,55,1,1,0,Group C
1433,Ear and labyrinth disorders,Ear pain,54,1,0,0,Group C
1434,Ear and labyrinth disorders,Ear pain,50,1,1,0,Group C
1435,Ear and labyrinth disorders,Ear pain,44,1,0,0,Group C
1436,Ear and labyrinth disorders,Ear pain,44,1,1,0,Group C
1437,Ear and labyrinth disorders,Ear pain,54,1,0,0,Group C
1438,Ear and labyrinth disorders,Ear pain,54,1,1,0,Group C
1439,Ear and labyrinth disorders,Ear pain,55,1,1,0,Group C
1440,Ear and labyrinth disorders,Ear pain,55,1,1,0,Group C
1441,Ear and labyrinth disorders,Ear pain,55,1,0,0,Group C
1442,Endocrine disorders,Adrenal insufficiency,46,1,0,0,Group C
1443,Endocrine disorders,Adrenal insufficiency,49,1,0,0,Group C
1444,Endocrine disorders,Adrenal insufficiency,53,1,1,0,Group C
1445,Endocrine disorders,Adrenal insufficiency,46,1,0,0,Group C
1446,Endocrine disorders,Adrenal insufficiency,46,1,0,0,Group C
1447,Endocrine disorders,Adrenal insufficiency,53,1,0,0,Group C
1448,Endocrine disorders,Adrenal insufficiency,53,1,0,0,Group C
1449,Endocrine disorders,Adrenal insufficiency,53,1,1,0,Group C
1450,Eye disorders,Blurred vision,56,1,0,0,Group C
1451,Eye disorders,Blurred vision,52,1,0,0,Group C
1452,Eye disorders,Blurred vision,55,1,0,0,Group C
1453,Eye disorders,Blurred vision,54,1,1,0,Group C
1454,Eye disorders,Blurred vision,55,1,0,0,Group C
1455,Eye disorders,Blurred vision,52,1,0,0,Group C
1456,Eye disorders,Blurred vision,54,1,0,0,Group C
1457,Gastrointestinal disorders,Abdominal distension,50,1,0,0,Group C
1458,Gastrointestinal disorders,Abdominal distension,44,1,0,0,Group C
1459,Gastrointestinal disorders,Abdominal distension,50,1,0,0,Group C
1460,Gastrointestinal disorders,Abdominal distension,50,1,0,0,Group C
1461,Gastrointestinal disorders,Abdominal distension,44,1,1,0,Group C
1462,Gastrointestinal disorders,Abdominal distension,50,1,0,0,Group C
1463,Gastrointestinal disorders,Abdominal distension,44,1,1,0,Group C
1464,Gastrointestinal disorders,Abdominal distension,50,1,1,0,Group C
1465,General disorders and administration site conditions,Chills,46,1,0,0,Group C
1466,General disorders and administration site conditions,Chills,49,1,1,0,Group C
1467,General disorders and administration site conditions,Chills,53,1,0,0,Group C
1468,General disorders and administration site conditions,Chills,56,1,0,0,Group C
1469,General disorders and administration site conditions,Chills,52,1,0,0,Group C
1470,General disorders and administration site conditions,Chills,55,1,0,0,Group C
1471,General disorders and administration site conditions,Chills,55,1,1,0,Group C
1472,General disorders and administration site conditions,Chills,46,1,0,0,Group C
1473,General disorders and administration site conditions,Chills,55,1,0,0,Group C
1474,General disorders and administration site conditions,Chills,49,1,0,0,Group C
1475,General disorders and administration site conditions,Chills,53,1,1,0,Group C
1476,General disorders and administration site conditions,Chills,56,1,0,0,Group C
1477,General disorders and administration site conditions,Chills,46,1,0,0,Group C
1478,General disorders and administration site conditions,Chills,49,1,0,0,Group C
1479,Hepatobiliary disorders,Bile duct stenosis,54,1,0,0,Group C
1480,Hepatobiliary disorders,Bile duct stenosis,54,1,0,0,Group C
1481,Hepatobiliary disorders,Bile duct stenosis,54,1,0,0,Group C
1482,Hepatobiliary disorders,Bile duct stenosis,54,1,0,0,Group C
1483,Hepatobiliary disorders,Bile duct stenosis,54,1,0,0,Group C
1484,Hepatobiliary disorders,Bile duct stenosis,54,1,0,0,Group C
1485,Immune system disorders,Allergic reaction,50,1,1,0,Group C
1486,Immune system disorders,Allergic reaction,44,1,0,0,Group C
1487,Immune system disorders,Allergic reaction,46,1,0,0,Group C
1488,Immune system disorders,Allergic reaction,49,1,1,0,Group C
1489,Immune system disorders,Allergic reaction,53,1,0,0,Group C
1490,Immune system disorders,Allergic reaction,56,1,0,0,Group C
1491,Immune system disorders,Allergic reaction,52,1,1,0,Group C
1492,Immune system disorders,Allergic reaction,46,1,0,0,Group C
1493,Immune system disorders,Allergic reaction,50,1,1,0,Group C
1494,Immune system disorders,Allergic reaction,44,1,1,0,Group C
1495,Immune system disorders,Allergic reaction,53,1,0,0,Group C
1496,Infections and infestations,Abdominal infection,55,1,0,0,Group C
1497,Infections and infestations,Abdominal infection,54,1,1,0,Group C
1498,Infections and infestations,Abdominal infection,50,1,0,0,Group C
1499,Infections and infestations,Abdominal infection,44,1,1,0,Group C
1500,Infections and infestations,Abdominal infection,55,1,1,0,Group C
1501,Infections and infestations,Abdominal infection,44,1,0,0,Group C
1502,Infections and infestations,Abdominal infection,50,1,0,0,Group C
1503,Infections and infestations,Abdominal infection,44,1,0,0,Group C
1504,Infections and infestations,Abdominal infection,54,1,1,0,Group C
1505,Infections and infestations,Abdominal infection,44,1,0,0,Group C
1506,"Injury, poisoning and procedural complications",Ankle fracture,46,1,1,0,Group C
1507,"Injury, poisoning and procedural complications",Ankle fracture,49,1,0,0,Group C
1508,"Injury, poisoning and procedural complications",Ankle fracture,53,1,1,0,Group C
1509,"Injury, poisoning and procedural complications",Ankle fracture,56,1,1,0,Group C
1510,"Injury, poisoning and procedural complications",Ankle fracture,52,1,1,0,Group C
1511,"Injury, poisoning and procedural complications",Ankle fracture,55,1,1,0,Group C
1512,"Injury, poisoning and procedural complications",Ankle fracture,54,1,1,0,Group C
1513,"Injury, poisoning and procedural complications",Ankle fracture,56,1,1,0,Group C
1514,"Injury, poisoning and procedural complications",Ankle fracture,56,1,1,0,Group C
1515,"Injury, poisoning and procedural complications",Ankle fracture,55,1,0,0,Group C
1516,"Injury, poisoning and procedural complications",Ankle fracture,53,1,0,0,Group C
1517,"Injury, poisoning and procedural complications",Ankle fracture,46,1,0,0,Group C
1518,"Injury, poisoning and procedural complications",Ankle fracture,53,1,0,0,Group C
1519,"Injury, poisoning and procedural complications",Ankle fracture,55,1,1,0,Group C
1520,Investigations,Activated partial thromboplastin time prolonged,50,1,0,0,Group C
1521,Investigations,Activated partial thromboplastin time prolonged,44,1,1,0,Group C
1522,Investigations,Activated partial thromboplastin time prolonged,46,1,1,0,Group C
1523,Investigations,Activated partial thromboplastin time prolonged,49,1,0,0,Group C
1524,Investigations,Activated partial thromboplastin time prolonged,53,1,1,0,Group C
1525,Investigations,Activated partial thromboplastin time prolonged,50,1,0,0,Group C
1526,Investigations,Activated partial thromboplastin time prolonged,49,1,0,0,Group C
1527,Investigations,Activated partial thromboplastin time prolonged,53,1,0,0,Group C
1528,Investigations,Activated partial thromboplastin time prolonged,44,1,1,0,Group C
1529,Metabolism and nutrition disorders,Acidosis,56,1,1,0,Group C
1530,Metabolism and nutrition disorders,Acidosis,52,1,1,0,Group C
1531,Metabolism and nutrition disorders,Acidosis,52,1,0,0,Group C
1532,Metabolism and nutrition disorders,Acidosis,52,1,0,0,Group C
1533,Metabolism and nutrition disorders,Acidosis,52,1,0,0,Group C
1534,Metabolism and nutrition disorders,Acidosis,56,1,1,0,Group C
1535,Metabolism and nutrition disorders,Acidosis,52,1,1,0,Group C
1536,Metabolism and nutrition disorders,Acidosis,56,1,1,0,Group C
1537,Metabolism and nutrition disorders,Acidosis,56,1,0,0,Group C
1538,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,55,1,0,0,Group C
1539,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,54,1,0,0,Group C
1540,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,50,1,1,0,Group C
1541,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,44,1,0,0,Group C
1542,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,46,1,1,0,Group C
1543,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,49,1,0,0,Group C
1544,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,44,1,1,0,Group C
1545,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,54,1,0,0,Group C
1546,Musculoskeletal and connective tissue disorders,Abdominal soft tissue necrosis,46,1,1,0,Group C
1547,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,53,1,1,0,Group C
1548,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,56,1,1,0,Group C
1549,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,52,1,1,0,Group C
1550,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,55,1,1,0,Group C
1551,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,54,1,0,0,Group C
1552,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,50,1,1,0,Group C
1553,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,44,1,0,0,Group C
1554,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,46,1,1,0,Group C
1555,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,53,1,1,0,Group C
1556,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,44,1,0,0,Group C
1557,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,52,1,1,0,Group C
1558,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Leukemia secondary to oncology chemotherapy,46,1,0,0,Group C
1559,Nervous system disorders,Abducens nerve disorder,49,1,1,0,Group C
1560,Nervous system disorders,Abducens nerve disorder,53,1,1,0,Group C
1561,Nervous system disorders,Abducens nerve disorder,56,1,0,0,Group C
1562,Nervous system disorders,Abducens nerve disorder,49,1,0,0,Group C
1563,Nervous system disorders,Abducens nerve disorder,56,1,1,0,Group C
1564,Nervous system disorders,Abducens nerve disorder,49,1,0,0,Group C
1565,Nervous system disorders,Abducens nerve disorder,56,1,1,0,Group C
1566,"Pregnancy, puerperium and perinatal conditions",Fetal death,52,1,1,0,Group C
1567,"Pregnancy, puerperium and perinatal conditions",Fetal death,55,1,0,0,Group C
1568,"Pregnancy, puerperium and perinatal conditions",Fetal death,54,1,0,0,Group C
1569,"Pregnancy, puerperium and perinatal conditions",Fetal death,50,1,0,0,Group C
1570,"Pregnancy, puerperium and perinatal conditions",Fetal death,50,1,0,0,Group C
1571,"Pregnancy, puerperium and perinatal conditions",Fetal death,54,1,0,0,Group C
1572,"Pregnancy, puerperium and perinatal conditions",Fetal death,52,1,1,0,Group C
1573,"Pregnancy, puerperium and perinatal conditions",Fetal death,52,1,0,0,Group C
1574,Psychiatric disorders,Agitation,44,1,1,0,Group C
1575,Psychiatric disorders,Agitation,46,1,0,0,Group C
1576,Psychiatric disorders,Agitation,46,1,0,0,Group C
1577,Psychiatric disorders,Agitation,46,1,0,0,Group C
1578,Psychiatric disorders,Agitation,44,1,0,0,Group C
1579,Psychiatric disorders,Agitation,46,1,1,0,Group C
1580,Psychiatric disorders,Agitation,46,1,1,0,Group C
1581,Psychiatric disorders,Agitation,44,1,0,0,Group C
1582,Psychiatric disorders,Agitation,44,1,1,0,Group C
1583,Psychiatric disorders,Agitation,44,1,1,0,Group C
1584,Psychiatric disorders,Agitation,44,1,1,0,Group C
1585,Psychiatric disorders,Agitation,46,1,0,0,Group C
1586,Reproductive system and breast disorders,Azoospermia,49,1,1,0,Group C
1587,Reproductive system and breast disorders,Azoospermia,53,1,1,0,Group C
1588,Reproductive system and breast disorders,Azoospermia,56,1,0,0,Group C
1589,Reproductive system and breast disorders,Azoospermia,52,1,0,0,Group C
1590,Reproductive system and breast disorders,Azoospermia,53,1,1,0,Group C
1591,Reproductive system and breast disorders,Azoospermia,56,1,0,0,Group C
1592,Reproductive system and breast disorders,Azoospermia,49,1,0,0,Group C
1593,Reproductive system and breast disorders,Azoospermia,52,1,1,0,Group C
1594,Reproductive system and breast disorders,Azoospermia,49,1,0,0,Group C
1595,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,55,1,1,0,Group C
1596,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,54,1,0,0,Group C
1597,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,50,1,1,0,Group C
1598,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,44,1,0,0,Group C
1599,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,46,1,1,0,Group C
1600,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,46,1,1,0,Group C
1601,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,44,1,1,0,Group C
1602,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,50,1,0,0,Group C
1603,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,50,1,0,0,Group C
1604,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,46,1,0,0,Group C
1605,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,50,1,0,0,Group C
1606,"Respiratory, thoracic and mediastinal disorders",Adult respiratory distress syndrome,46,1,0,0,Group C
1607,Skin and subcutaneous tissue disorders,Alopecia,49,1,1,0,Group C
1608,Skin and subcutaneous tissue disorders,Alopecia,53,1,1,0,Group C
1609,Skin and subcutaneous tissue disorders,Alopecia,49,1,1,0,Group C
1610,Social circumstances,Menopause,56,1,0,0,Group C
1611,Social circumstances,Menopause,52,1,1,0,Group C
1612,Social circumstances,Menopause,55,1,1,0,Group C
1613,Social circumstances,Menopause,54,1,1,0,Group C
1614,Social circumstances,Menopause,50,1,1,0,Group C
1615,Social circumstances,Menopause,44,1,1,0,Group C
1616,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",46,1,0,0,Group C
1617,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",49,1,0,0,Group C
1618,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",53,1,1,0,Group C
1619,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",53,1,1,0,Group C
1620,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",46,1,1,0,Group C
1621,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",49,1,0,0,Group C
1622,Surgical and medical procedures,"Surgical and medical procedures - Other, specify",49,1,1,0,Group C
1623,Vascular disorders,Capillary leak syndrome,50,1,0,1,Group C
1624,Vascular disorders,Capillary leak syndrome,56,1,0,0,Group C
1625,Vascular disorders,Capillary leak syndrome,52,1,0,0,Group C
1626,Vascular disorders,Capillary leak syndrome,55,1,1,0,Group C
1627,Vascular disorders,Capillary leak syndrome,54,1,1,0,Group C
1628,Vascular disorders,Capillary leak syndrome,44,1,1,0,Group C
1629,Vascular disorders,Capillary leak syndrome,46,1,1,0,Group C
1630,Vascular disorders,Capillary leak syndrome,49,1,1,0,Group C
1631,Vascular disorders,Capillary leak syndrome,53,1,0,0,Group C
1632,Vascular disorders,Capillary leak syndrome,44,1,1,0,Group C
1633,Vascular disorders,Capillary leak syndrome,49,1,1,0,Group C
1634,Vascular disorders,Capillary leak syndrome,56,1,1,0,Group C
1635,Vascular disorders,Capillary leak syndrome,54,1,0,0,Group C
1636,Vascular disorders,Capillary leak syndrome,55,1,0,0,Group C
1637,Vascular disorders,Capillary leak syndrome,56,1,1,0,Group C
1638,Vascular disorders,Capillary leak syndrome,54,1,1,0,Group C
